1
|
Qi D, Wang W, Chu L, Wu Y, Wang W, Zhu M, Yuan L, Gao W, Deng H. Associations of schizophrenia with the activities of the HPA and HPG axes and their interactions characterized by hair-based biomarkers. Psychoneuroendocrinology 2024; 165:107049. [PMID: 38657340 DOI: 10.1016/j.psyneuen.2024.107049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2024] [Revised: 03/11/2024] [Accepted: 04/10/2024] [Indexed: 04/26/2024]
Abstract
BACKGROUND Past studies on schizophrenia (SCZ) and the stress-sensitive neuroendocrine systems have mostly focused on a single system and traditionally utilized acute biomarkers (e.g., biomarkers from blood, urine and saliva) that poorly match the chronic course of schizophrenia in time span. Using eight biomarkers in hair, this study aimed to explore the functional characteristics of SCZ patients in the hypothalamic-pituitary-adrenocortical (HPA) and hypothalamic-pituitary-gonadal (HPG) axes and the interaction between the two axes. METHODS Hair samples were taken from 137 SCZ patients and 73 controls. The SCZ patients were diagnosed by their attending physician according to the Diagnostic and Statistical Manual of Mental Disorders IV and were clinically stable after treatment. Gender, age, BMI, frequency of hair washing, marital status, education level, family history of mental illness and clozapine dosage were concurrently collected as covariates. The 10-item perceived stress scale (PSS-10) and the social readjustment rating scale were used to assess chronic stress status in SCZ patients. Eight hair biomarkers, cortisol, cortisone, dehydroepiandrosterone (DHEA), testosterone, progesterone, cortisol/cortisone, cortisol/DHEA and cortisol/testosterone, were measured by high performance liquid chromatography tandem mass spectrometer. Among them, cortisol, cortisone, DHEA and cortisol/DHEA reflected the functional activity of the HPA axis, and testosterone and progesterone reflected the functional activity of the HPG axis, and cortisol/cortisone reflected the activity of 11β-hydroxysteroid dehydrogenase types 2 (11β-HSD 2), and cortisol/testosterone reflected the HPA-HPG interaction. RESULTS SCZ patients showed significantly higher cortisone and cortisol/testosterone than controls (p<0.001, η²p=0.180 and p=0.015, η²p=0.031), lower testosterone (p=0.009, η²p=0.034), progesterone (p<0.001, η²p=0.069) and cortisol/cortisone (p=0.001, η²p=0.054). There were significant intergroup differences in male and female progesterone (p=0.003, η²p=0.088 and p=0.030, η²p=0.049) and female testosterone (p=0.028, η²p=0.051). In SCZ patients, cortisol, cortisol/cortisone, cortisol/DHEA and cortisol/testosterone were positively associated with PSS-10 score (ps<0.05, 0.212 CONCLUSION The function of the HPA and HPG axes, the activity of 11β-HSD 2 and the HPA-HPG interaction were abnormal in SCZ patients. The abnormality of neuroendocrine systems was associated with chronic stress status in SCZ patients. This study provided evidence for abnormalities in the neuroendocrine systems in SCZ patients.
Collapse
Affiliation(s)
- Deyi Qi
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Weiliang Wang
- School of Nursing, Harbin Medical University, Harbin 163319, China.
| | - Liuxi Chu
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Yan Wu
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Wei Wang
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Minhui Zhu
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Lin Yuan
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China
| | - Wei Gao
- Institute of Child Development and Education, Southeast University, Nanjing 211189, China; School of Psychology, Nanjing Normal University, Nanjing 210024, China
| | - Huihua Deng
- Department of Brain and Learning Science, School of Biological Science & Medical Engineering, Southeast University, Nanjing 211189, China; Key Laboratory of Child Development and Learning Science (Southeast University), Ministry of Education, Nanjing 211189, China; Institute of Child Development and Education, Southeast University, Nanjing 211189, China.
| |
Collapse
|
2
|
Jiang B, Wan JY, Tian YY, Xu R, Ma JL, Li J, Yu YX, Hu LK, Hu CH, Zhu M. [Arterial spin labeling in assessment of interstitial fibrosis in renal allografts]. Zhonghua Yi Xue Za Zhi 2024; 104:276-281. [PMID: 38246772 DOI: 10.3760/cma.j.cn112137-20230726-00095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/23/2024]
Abstract
Objective: To explore the feasibility and application value of arterial spin labeling (ASL) in evaluating the degree of renal fibrosis after kidney transplantation. Methods: This is a cross-sectional study. Renal transplant recipients who received treatment at the First Affiliated Hospital of Soochow University from December 2021 to December 2022 were enrolled. All participants underwent ASL scan, and the values of renal cortical renal blood flow (RBF) were measured through post-processing software. The participants were divided into different groups according to the Banff interstitial fibrosis score (ci score) of the transplanted kidneys, and then relevant indicators were compared. One-way analysis of variance was conducted to compare the differences in renal cortical RBF among the groups. Spearman correlation analysis was employed to investigate the association between renal cortical RBF and ci score of the transplanted kidney. Receiver operating characteristic curve was used to analyze the diagnostic effectiveness of renal cortical RBF and laboratory indicators for distinguishing varying degrees of fibrosis in transplanted kidneys. The Delong test was utilized to compare the area under the curve (AUC). Results: A total of 60 patients (42 males and 18 females) were included in the study, with a mean age of (44.6±10.8) years. All patients were divided into 4 groups: ci0 group (ci score=0, 11 cases), ci1 group (ci score=1, 21 cases), ci2 group (ci score=2, 20 cases), and ci3 group (ci score=3, 8 cases). With an increase in the degree of fibrosis in the transplanted kidney, there was a corresponding decrease in the renal cortical RBF value. The differences in renal cortical RBF values among the 4 groups were statistically significant[ci0 group: (214.9±28.5) ml·(100 g)-1·min-1; ci1 group: (181.7±29.3) ml·(100 g)-1·min-1; ci2 group: (158.8±39.2) ml·(100 g)-1·min-1; ci3 group: (123.1±27.2) ml·(100 g)-1·min-1; F=14.02, P<0.001]. The renal cortical RBF was moderately negatively correlated with the ci score (r=-0.644, P<0.001). The AUC for discriminating between ci0 and ci1-3 of renal cortical RBF and 24-hour urine protein was 0.881 (95%CI: 0.772-0.950) and 0.680 (95%CI: 0.547-0.795), respectively. The AUC for renal cortical RBF was significantly higher than that for 24-hour urine protein (P=0.047). The renal cortical RBF can distinguish between ci0-1 and ci2-3, as well as ci0-2 and ci3, with the corresponding AUC value of 0.796 (95%CI: 0.673-0.889) and 0.900 (95%CI: 0.795-0.963), respectively. Conclusion: ASL can quantitatively assess renal blood perfusion in transplanted kidneys and demonstrates high operational efficacy in distinguishing varying degrees of fibrosis in the transplanted kidneys.
Collapse
Affiliation(s)
- B Jiang
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - J Y Wan
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - Y Y Tian
- Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - R Xu
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - J L Ma
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - J Li
- Suzhou Medical College of Soochow University, Suzhou 215006, China
| | - Y X Yu
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - L K Hu
- Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - C H Hu
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| | - M Zhu
- Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China
| |
Collapse
|
3
|
Liu H, Li W, Zhu M, Wen X, Jin J, Wang H, Lv D, Zhao S, Wu X, Jiao J. Myokines and Biomarkers of Frailty in Older Inpatients with Undernutrition: A Prospective Study. J Frailty Aging 2024; 13:82-90. [PMID: 38616363 DOI: 10.14283/jfa.2024.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/16/2024]
Abstract
BACKGROUND Population aging might increase the prevalence of undernutrition in older people, which increases the risk of frailty. Numerous studies have indicated that myokines are released by skeletal myocytes in response to muscular contractions and might be associated with frailty. This study aimed to evaluate whether myokines are biomarkers of frailty in older inpatients with undernutrition. METHODS The frailty biomarkers were extracted from the Gene Expression Omnibus and Genecards datasets. Relevant myokines and health-related variables were assessed in 55 inpatients aged ≥ 65 years from the Peking Union Medical College Hospital prospective longitudinal frailty study. Serum was prepared for enzyme-linked immunosorbent assay using the appropriate kits. Correlations between biomarkers and frailty status were calculated by Spearman's correlation analysis. Multiple linear regression was performed to investigate the association between factors and frailty scores. RESULTS The prevalence of frailty was 13.21%. The bioinformatics analysis indicated that leptin, adenosine 5'-monophosphate-activated protein kinase (AMPK), irisin, decorin, and myostatin were potential biomarkers of frailty. The frailty group had significantly higher concentrations of leptin, AMPK, and MSTN than the robust group (p < 0.05). AMPK was significantly positively correlated with frailty (p < 0.05). The pre-frailty and frailty groups had significantly lower concentrations of irisin than the robust group (p < 0.05), whereas the DCN concentration did not differ among the groups. Multiple linear regression suggested that the 15 factors influencing the coefficients of association, the top 50% were the ADL score, MNA-SF score, serum albumin concentration, urination function, hearing function, leptin concentration, GDS-15 score, and MSTN concentration. CONCLUSIONS Proinflammatory myokines, particularly leptin, myostatin, and AMPK, negatively affect muscle mass and strength in older adults. ADL and nutritional status play major roles in the development of frailty. Our results confirm that identification of frailty relies upon clinical variables, myokine concentrations, and functional parameters, which might enable the identification and monitoring of frailty.
Collapse
Affiliation(s)
- H Liu
- Hongpeng Liu, Peking University School of Nursing, Beijing, China, ; Xinjuan Wu,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Shi Z, Zhang M, Wang X, Zhu M, Ye X. Anchoring flap suture technique to repair a wound with exposed bone after hip disarticulation: a case report and brief review of the literature. Wounds 2023; 35:E403-E407. [PMID: 38048619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/06/2023]
Abstract
BACKGROUND In specific clinical scenarios characterized by poor tissue conditions surrounding a wound, achieving stable flap fixation with standard sutures can be challenging. The anchoring flap suture technique, which is commonly used for soft tissue-to-bone attachment in cases of injury, may be an alternative and effective approach. CASE REPORT This report describes the successful application of the anchoring flap suture technique to repair a wound with exposed bone in a 39-year-old female patient. She presented with a 7% TBSA wound of the left trunk following hip disarticulation. After 4 operations, a wound with exposed iliac bone remained. Given the compromised condition of the tissues surrounding the exposed bone, the authors opted to anchor a local flap directly to the exposed bone. Steady flap fixation was achieved using the anchoring flap suture method, resulting in complete healing of that wound. Remarkably, no short- or long-term complications associated with the flap were observed. Three months after hospital discharge, the patient regained mobility, walking on 1 leg with the assistance of a 4-legged walker. CONCLUSION The anchoring flap suture technique seems to be a reliable and effective treatment option, particularly in cases in which inadequate soft tissue precludes the use of traditional flap fixation using standard sutures.
Collapse
Affiliation(s)
- Zhiyuan Shi
- The Fourth Medical Center of PLA General Hospital, Beijing, China
| | - Ming Zhang
- The Fourth Medical Center of PLA General Hospital, Beijing, China
| | - Xingtong Wang
- The Fourth Medical Center of PLA General Hospital, Beijing, China
| | - Minhui Zhu
- The Fourth Medical Center of PLA General Hospital, Beijing, China
| | - Xiangbo Ye
- The Fourth Medical Center of PLA General Hospital, Beijing, China
| |
Collapse
|
5
|
Zhu G, Wang W, Yao H, Li H, Zhang C, Meng Y, Wang J, Zhu M, Zheng H. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma. Sci Rep 2023; 13:18763. [PMID: 37907576 PMCID: PMC10618291 DOI: 10.1038/s41598-023-45976-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 10/26/2023] [Indexed: 11/02/2023] Open
Abstract
The role of 5-methylcytosine (m5C) in tumor initiation and progression has been increasingly recognized. However, the precise association between the regulation of m5C and the progression, metastasis, and prognosis of head and neck squamous cell carcinoma (HNSCC) has not yet been fully explored. Data from 545 HNSCC patients obtained from The Cancer Genome Atlas (TCGA) database were analyzed. Unsupervised cluster analysis was conducted using the expression levels of m5C regulatory genes. Additionally, gene set variation analysis (GSVA), single-sample gene set enrichment analysis (ssGSEA), and Cox regression analysis were utilized. Quantitative reverse transcription polymerase chain reaction (RT-qPCR), colony formation assay, transwell experiments and western blots were performed in the HNSCC cell line UM-SCC-17B to assess the expression and functional role of one of the novel signatures, CNFN. Significant expression differences were found in m5C regulatory genes between tumor and normal tissues in HNSCC. Two distinct m5C modification patterns, characterized by substantial prognostic differences, were identified. Cluster-2, which exhibited a strong association with epithelial-mesenchymal transition (EMT), was found to be associated with a poorer prognosis. Based on the m5C clusters and EMT status, differentially expressed genes (DEGs) were identified. Using DEGs, an 8-gene signature (CAMK2N1, WNT7A, F2RL1, AREG, DEFB1, CNFN, TGFBI, and CAV1) was established to develop a prognostic model. The performance of this signature was validated in both the training and external validation datasets, demonstrating its promising efficacy. Furthermore, additional investigations using RT-qPCR on clinical specimens and experimental assays in cell lines provided compelling evidence suggesting that CNFN, one of the genes in the signature, could play a role in HNSCC progression and metastasis through the EMT pathway. This study highlighted the role of m5C in HNSCC progression and metastasis. The relationship between m5C and EMT has been elucidated for the first time. A robust prognostic model was developed for accurately predicting HNSCC patients' survival outcomes. Potential molecular mechanisms underlying these associations have been illuminated through this research.
Collapse
Affiliation(s)
- Guanghao Zhu
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Wei Wang
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Hui Yao
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Haopu Li
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Caiyun Zhang
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Yindi Meng
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Jingjie Wang
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China
| | - Minhui Zhu
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China.
| | - Hongliang Zheng
- Department of Otolaryngology Head and Neck Surgery, Shanghai Changhai Hospital, The Second Military Medical University, Shanghai, China.
| |
Collapse
|
6
|
Duan X, Zhu M, Zhang C, Li M, Cai Y, Chen S, Zheng H. Evaluation of modified coblation endoscopic lingual lightening in multilevel surgery for obstructive sleep apnea hypopnea syndrome: an open intervention study. Sleep Breath 2023:10.1007/s11325-023-02912-2. [PMID: 37843682 DOI: 10.1007/s11325-023-02912-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Revised: 07/30/2023] [Accepted: 09/04/2023] [Indexed: 10/17/2023]
Abstract
PURPOSE To evaluate the efficacy and safety of modified coblation endoscopic lingual lightening to address retrolingual obstruction in multilevel surgery for obstructive sleep apneae (OSA). METHODS Patients with OSA due to retropalatal and retrolingual obstructions were enrolled. Group 1 consisted of patients who underwent modified coblation endoscopic lingual lightening combined with H-uvulopalatopharyngoplasty, while group 2 comprised patients treated by H-uvulopalatopharyngoplasty alone. Objective parameters and subjective evaluations were recorded preoperatively and at 6 months postoperatively. RESULTS The mean (standard deviation) apnea-hypopnea index (AHI) declined from 51.5 (18.9) to 14.3 (7.2) in group 1, and from 51.7 (15.8) to 28.5 (16.9) in group 2. The mean (standard deviation) percentage change in AHI was higher in group 1 than in group 2 (73.2 [10.9] vs. 48.9 [22.4], P < 0.01). The surgical response rate differed significantly between groups 1 and 2 (88.5 [23/26] vs. 46.7 [14/30], P < 0.01). Other outcomes, including the lowest oxygen saturation, Epworth Sleepiness Scale score, snoring visual analog scale score, and subjective improvement rate, were also significantly better in group 1 than in group 2. CONCLUSION Without increasing complications, modified coblation endoscopic lingual lightening significantly improved surgical outcomes as part of multilevel surgery in patients with OSA due to multilevel obstruction.
Collapse
Affiliation(s)
- Xiangqiang Duan
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China
| | - Minhui Zhu
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China
| | - Caiyun Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China
| | - Meng Li
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China
| | - Yupeng Cai
- Department of Medical Imaging, The First Affiliated Hospital of Naval Medical University, Shanghai City, China
| | - Shicai Chen
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China
| | - Hongliang Zheng
- Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Naval Medical University, No. 168, Changhai Rd, Shanghai City, 200433, China.
| |
Collapse
|
7
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Fu JF. [Summary of the 22 nd National Pediatric Endocrine and Genetic Metabolic Diseases Conference]. Zhonghua Er Ke Za Zhi 2023; 61:958-959. [PMID: 37803871 DOI: 10.3760/cma.j.cn112140-20230804-00077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Affiliation(s)
- W Wu
- Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| | - W Wu
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - C X Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J F Fu
- Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| |
Collapse
|
8
|
Xia CM, Zhu M, Zhu LF, Ji PZ, Wu PF, Yang YL, Liu B, Ma YC. [Research progress in the regulation of tumor cell PD-L1 expression by N6-methyladenosine modification]. Zhonghua Bing Li Xue Za Zhi 2023; 52:976-980. [PMID: 37670637 DOI: 10.3760/cma.j.cn112151-20221201-01012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/07/2023]
Affiliation(s)
- C M Xia
- Department of Pathology, 940th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Lanzhou 730000, China
| | - M Zhu
- Department of Pathology, Gansu University of Chinese Medicine, Lanzhou 730000, China
| | - L F Zhu
- School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China
| | - P Z Ji
- Department of Pathology, 940th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Lanzhou 730000, China
| | - P F Wu
- Department of Pathology, Gansu University of Chinese Medicine, Lanzhou 730000, China
| | - Y L Yang
- Department of Pathology, 940th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Lanzhou 730000, China
| | - B Liu
- Department of Pathology, 940th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Lanzhou 730000, China
| | - Y C Ma
- Department of Pathology, 940th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Lanzhou 730000, China
| |
Collapse
|
9
|
Wang XD, Zhu M. [Sequential treatment of oral and maxillofacial deformities with hemifacial microsomia]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:781-790. [PMID: 37550038 DOI: 10.3760/cma.j.cn112144-20230420-00167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/09/2023]
Abstract
The incidence of the first and second branchial arch syndrome namely hemifacial microsomia (HFM) is the second only to cleft lip and palate, and it is a very common craniofacial developmental deformity. This congenital condition affects the development of the orbit, ear, and mandible, and the clinical manifestations of each patient are significantly heterogeneous. Clinical treatment needs to formulate corresponding treatment measures according to different degrees of tissue deformity at different ages. This article puts forward personal suggestions for the sequential treatment of oral and maxillofacial deformities of HFM from the perspective of patient age and classification.
Collapse
Affiliation(s)
- X D Wang
- Department of Oral & Cranio-maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China
| | - M Zhu
- Department of Oral & Cranio-maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine & College of Stomatology, Shanghai Jiao Tong University & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai 200011, China
| |
Collapse
|
10
|
Zhu M, Li J, Zheng WH, Wu MJ. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma]. Zhonghua Bing Li Xue Za Zhi 2023; 52:820-826. [PMID: 37527987 DOI: 10.3760/cma.j.cn112151-20230111-00028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 08/03/2023]
Abstract
Objective: To investigate the clinicopathological features, immunophenotype and gene alterations of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma (TL-LGNPPA). Methods: Fifteen case of TL-LGNPPA diagnosed at Zhejiang Cancer Hospital (5 cases) and the First Affiliated Hospital, Zhejiang University School of Medicine (10 cases) from November 2011 to August 2020 were collected. Clinical and pathological examinations, immunohistochemical staining and next-generation sequencing were performed. The clinicopathological and molecular characteristics were summarized, and relevant literature was reviewed. Results: Fifteen patients were identified and included. Their median age was 36 years (range, 20-60 years). The male-female ratio was 1.0∶1.1. The most common symptoms were epistaxis and nasal obstruction. The neoplasms were located on the roof of the nasopharynx or the posterior margin of the nasal septum. The pathological features included complex papillary and glandular structures mainly composed of single or pseudostratified cubic and columnar cells, with mild to moderate cytological atypia. In some cases, spindle cell features, nuclear grooves, ground glass nuclei, squamous metaplasia, or scattered psammoma bodies were identified. In addition, nuclear polar reversal cells, hobnail cells and micropapillary structures were found, but have not been reported in previous literature. Immunohistochemistry showed that the tumor cells were diffusely positive for TTF1, CK7, vimentin and CKpan; focally positive for p40, CK5/6 and p16; and negative for Tg, NapsinA, CK20, CDX2, S-100 and PAX8. The Ki-67 positive rates ranged from 1% to 20% and were≤10% in thirteen cases (13/15). EBER in situ hybridization was negative in all cases. DNA sequencing of 6 specimens was performed and all specimens were found harboring gene mutations (EWSR1, SMAD2, ROS1, JAK3, GRIN2A, ERRCC5, STAT3, and TET2), but no hot spot gene alterations were found. No MSI-H and MMR related gene changes were detected. All tumors showed low tumor mutation burden. All 15 patients underwent endoscopic surgery, and only 1 of them underwent radiotherapy postoperatively. All patients were recurrence free and alive at the end of follow-up periods (range: 23 to 129 months). Conclusions: TL-LGNPPA is a rare indolent tumor of the nasopharynx and exhibits a unique morphology and immunophenotype. Endoscopic resection is an effective treatment for TL-LGNPPA with excellent overall prognosis.
Collapse
Affiliation(s)
- M Zhu
- Department of Thyroid, Zhejiang Cancer Hospital, Hangzhou 310022, China
| | - J Li
- Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
| | - W H Zheng
- Department of Head and Neck, Zhejiang Cancer Hospital, Hangzhou 310022, China
| | - M J Wu
- Department of Pathology, Zhejiang Cancer Hospital, Hangzhou 310022, China
| |
Collapse
|
11
|
Zhang J, Ma ZM, Wang H, Fu YT, Ji C, Zhu M, Shen HB, Ma HX. [Association between chronic lung diseases and the risk of lung cancer in UK Biobank: observational and Mendelian randomization analyses]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:1147-1152. [PMID: 37574304 DOI: 10.3760/cma.j.cn112150-20221115-01112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/15/2023]
Abstract
Objective: To investigate the association between chronic lung diseases and the risk of lung cancer. Methods: Using UK Biobank (UKB) survey data, 472 397 participants who had not previously been diagnosed with cancer and whose self-reported sex was consistent with their genetic sex were studied. Information on the prevalence of previous chronic lung diseases, general demographic characteristics and the prevalence of lung cancer was collected using baseline questionnaires and national health system data. The multivariate Cox proportional risk regression model was used to analyze the association between four previous chronic lung diseases (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and interstitial pulmonary disease) and the risk of lung cancer. A total of 458 526 participants with genotype data in the observational study were selected as research objects, and the closely related and independent genetic loci with four chronic lung diseases were selected as instrumental variables, and the association between four chronic lung diseases and the risk of lung cancer was analyzed by Mendelian randomization (MR). The dose-response relationship between genetic risk score and the risk of lung cancer in different chronic lung diseases was evaluated using a restricted cubic spline function. Results: The age [M (Q1, Q3)] of the subjects was 57 (50, 63) years old, and there were 3 516 new cases of lung cancer (0.74%) during follow-up. The multivariate Cox proportional hazard regression model analysis showed that previous chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis were associated with the risk of lung cancer, about 1.61 (1.49-1.75) and 2.61 (1.24-5.49), respectively. MR Studies showed that genetically predicted chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis were associated with the risk of lung cancer, with HR (95%CI) of 1.10 (1.03-1.19) and 1.04 (1.01-1.08), respectively. The results of restricted cubic spline function analysis showed that the risk of lung cancer increased linearly with the increase of genetic risk scores for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis (P<0.05). Neither observational studies nor Mendelian randomization analysis found an association between previous asthma or interstitial lung disease and the risk of lung cancer (both P values>0.05). Conclusion: Chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis are potential risk factors for lung cancer.
Collapse
Affiliation(s)
- J Zhang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - Z M Ma
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - H Wang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - Y T Fu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - C Ji
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - M Zhu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - H B Shen
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - H X Ma
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| |
Collapse
|
12
|
Pan Z, Lu JG, Jiang P, Han JL, Chen HL, Han ZW, Liu K, Qian L, Xu RX, Zhang B, Luo JT, Yan Z, Yang ZL, Zhou DJ, Wang PF, Wang C, Li MH, Zhu M. A binary pulsar in a 53-minute orbit. Nature 2023; 620:961-964. [PMID: 37339734 PMCID: PMC10468392 DOI: 10.1038/s41586-023-06308-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Accepted: 06/12/2023] [Indexed: 06/22/2023]
Abstract
Spider pulsars are neutron stars that have a companion star in a close orbit. The companion star sheds material to the neutron star, spinning it up to millisecond rotation periods, while the orbit shortens to hours. The companion is eventually ablated and destroyed by the pulsar wind and radiation1,2. Spider pulsars are key for studying the evolutionary link between accreting X-ray pulsars and isolated millisecond pulsars, pulsar irradiation effects and the birth of massive neutron stars3-6. Black widow pulsars in extremely compact orbits (as short as 62 minutes7) have companions with masses much smaller than 0.1 M⊙. They may have evolved from redback pulsars with companion masses of about 0.1-0.4 M⊙ and orbital periods of less than 1 day8. If this is true, then there should be a population of millisecond pulsars with moderate-mass companions and very short orbital periods9, but, hitherto, no such system was known. Here we report radio observations of the binary millisecond pulsar PSR J1953+1844 (M71E) that show it to have an orbital period of 53.3 minutes and a companion with a mass of around 0.07 M⊙. It is a faint X-ray source and located 2.5 arcminutes from the centre of the globular cluster M71.
Collapse
Affiliation(s)
- Z Pan
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- Guizhou Radio Astronomical Observatory, Guizhou University, Guiyang, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - J G Lu
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- Guizhou Radio Astronomical Observatory, Guizhou University, Guiyang, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - P Jiang
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China.
- Guizhou Radio Astronomical Observatory, Guizhou University, Guiyang, People's Republic of China.
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China.
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China.
| | - J L Han
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China.
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China.
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China.
| | - H-L Chen
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, People's Republic of China
| | - Z W Han
- Yunnan Observatories, Chinese Academy of Sciences, Kunming, People's Republic of China
- University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - K Liu
- Max-Planck-Institut für Radioastronomie, Bonn, Germany
| | - L Qian
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- Guizhou Radio Astronomical Observatory, Guizhou University, Guiyang, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - R X Xu
- Department of Astronomy, Peking University, Beijing, People's Republic of China
- Kavli Institute for Astronomy and Astrophysics, Peking University, Beijing, People's Republic of China
- State Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, People's Republic of China
| | - B Zhang
- Nevada Center for Astrophysics, University of Nevada, Las Vegas, NV, USA.
- Department of Physics and Astronomy, University of Nevada, Las Vegas, NV, USA.
| | - J T Luo
- National Time Service Center, Chinese Academy of Sciences, Xi'an, China
| | - Z Yan
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
- Shanghai Astronomical Observatory, Chinese Academy of Sciences, Shanghai, People's Republic of China
| | - Z L Yang
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - D J Zhou
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - P F Wang
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - C Wang
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| | - M H Li
- State Key Laboratory of Public Big Data, Guizhou University, Guiyang, People's Republic of China
| | - M Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, Beijing, People's Republic of China
- Guizhou Radio Astronomical Observatory, Guizhou University, Guiyang, People's Republic of China
- College of Astronomy and Space Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, People's Republic of China
- Key Laboratory of Radio Astronomy and Technology, Chinese Academy of Sciences, Beijing, People's Republic of China
| |
Collapse
|
13
|
Li H, Zhao X, Xie J, Zhu X, Su Y, He C, Ding J, Zhu M, Xu Y, Wang Y, Shan R, Liu B, Ding Y, Liu Y, Zhou H, Xie Y. A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin ® in healthy Chinese male subjects. BMC Pharmacol Toxicol 2023; 24:36. [PMID: 37245022 DOI: 10.1186/s40360-023-00673-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Accepted: 05/09/2023] [Indexed: 05/29/2023] Open
Abstract
BACKGROUND The biosimilar landscape for malignancies continues to grow, with several biosimilars for reference product bevacizumab currently available. Bevacizumab has been shown to be well tolerated; however, the safety of recombinant humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody injection remains unclear. This study aimed to compare the pharmacokinetics (PK), safety, and immunogenicity of recombinant humanized anti-VEGF monoclonal antibody injection to that of Avastin® in healthy Chinese male volunteers. METHODS A randomized, double-blind, single-dose, and parallel-group study was performed on 88 healthy men who randomly (1:1) received either the test drug as an intravenous infusion of 3 mg/kg or Avastin®. The primary PK parameter was area under the serum concentration-time curve (AUC) from time zero to last quantifiable concentration (AUC0-t). Secondary endpoints included maximum observed serum concentration (Cmax), AUC from 0 extrapolated to infinity (AUCinf), safety, and immunogenicity. Serum bevacizumab concentrations were measured using a validated enzyme-linked immunosorbent assay (ELISA). RESULTS The baseline characteristics were similar among the two groups. The 90% confidence interval (CI) for the geometric mean ratio of AUC0-t, Cmax and AUCinf between the test group and reference group were 91.71%-103.18%, 95.72%-107.49% and 91.03%-103.43%, respectively. These values were within the predefined bioequivalence margin of 80.00%-125.00%, demonstrating the biosimilarity of the test drug and Avastin®. Eighty-one treatment-emergent adverse events were reported, with a comparable incidence among the test group (90.91%) and the reference group (93.18%). No serious adverse events were reported. The incidence of ADA antibodies in the two groups was low and similar. CONCLUSION In healthy Chinese men, PK similarity of recombinant humanized anti-VEGF monoclonal antibody injection to Avastin® was confirmed, with comparable safety and immunogenicity. Subsequent studies should investigate recombinant humanized anti-VEGF monoclonal antibody injection in patients setting. TRIAL REGISTRATION Registered 08/10/2019, CTR20191923.
Collapse
Affiliation(s)
- Hongtao Li
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Xiangdi Zhao
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Jing Xie
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Xingyu Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Yue Su
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China
| | - Cuixia He
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Jiaxiang Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China
| | - Minhui Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Yuanyuan Xu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Ying Wang
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Rongfang Shan
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Bingyan Liu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Yuzhou Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Yuanyuan Liu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Huan Zhou
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
- School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China.
- School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China.
| | - Yunqiu Xie
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
- Department of Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
| |
Collapse
|
14
|
Liu L, Zhu M, Wang Y, Wan B, Jiang Z. [Molecular pathological mechanism of liver metabolic disorder in mice with severe spinal muscular atrophy]. Nan Fang Yi Ke Da Xue Xue Bao 2023; 43:852-858. [PMID: 37313828 DOI: 10.12122/j.issn.1673-4254.2023.05.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVE To explore the molecular pathological mechanism of liver metabolic disorder in severe spinal muscular atrophy (SMA). METHODS The transgenic mice with type Ⅰ SMA (Smn-/- SMN20tg/2tg) and littermate control mice (Smn+/- SMN20tg/2tg) were observed for milk suckling behavior and body weight changes after birth. The mice with type Ⅰ SMA mice were given an intraperitoneal injection of 20% glucose solution or saline (15 μL/12 h), and their survival time was recorded. GO enrichment analysis was performed using the RNA-Seq data of the liver of type Ⅰ SMA and littermate control mice, and the results were verified using quantitative real-time PCR. Bisulfite sequencing was performed to examine CpG island methylation level in Fasn gene promoter region in the liver of the neonatal mice. RESULTS The neonatal mice with type Ⅰ SMA showed normal milk suckling behavior but had lower body weight than the littermate control mice on the second day after birth. Intraperitoneal injection of glucose solution every 12 h significantly improved the median survival time of type Ⅰ SMA mice from 9±1.3 to 11± 1.5 days (P < 0.05). Analysis of the RNA-Seq data of the liver showed that the expression of the target genes of PPARα related to lipid metabolism and mitochondrial β oxidation were down-regulated in the liver of type Ⅰ SMA mice. Type Ⅰ SMA mice had higher methylation level of the Fasn promoter region in the liver than the littermate control mice (76.44% vs 58.67%). In primary cultures of hepatocytes from type Ⅰ SMA mice, treatment with 5-AzaC significantly up-regulated the expressions of the genes related to lipid metabolism by over 1 fold (P < 0.01). CONCLUSION Type Ⅰ SMA mice have liver metabolic disorder, and the down-regulation of the target genes of PPARα related to lipid and glucose metabolism due to persistent DNA methylation contributes to the progression of SMA.
Collapse
Affiliation(s)
- L Liu
- Suzhou Medical College of Soochow University, Suzhou 215000, China
| | - M Zhu
- Suzhou Medical College of Soochow University, Suzhou 215000, China
| | - Y Wang
- Suzhou Medical College of Soochow University, Suzhou 215000, China
| | - B Wan
- Suzhou Medical College of Soochow University, Suzhou 215000, China
| | - Z Jiang
- Suzhou Medical College of Soochow University, Suzhou 215000, China
| |
Collapse
|
15
|
Li X, Liu Y, Zhu M, He C, Xu Y, Ding J, Wang Y, Shan R, Liu B, Ding Y, Xie J, Zhou H, Wang Z, Liu Y. Drug-drug interaction potential of SH-1028, a third-generation EGFR-TKI: in vitro and clinical trials. Invest New Drugs 2023:10.1007/s10637-023-01356-5. [PMID: 37129838 DOI: 10.1007/s10637-023-01356-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Accepted: 03/27/2023] [Indexed: 05/03/2023]
Abstract
SH-1028 is an irreversible third-generation EGFR tyrosine kinase inhibitor (EGFR-TKI) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). Considering the possibility of combination therapy in patients with NSCLC, we investigated the drug-drug interaction (DDI) potential of SH-1028 both in vitro and in clinical trials. The in vitro studies were conducted to determine the potential of SH-1028 as a substrate, inducer, or inhibitor of cytochrome P450 (CYP) subtypes. A phase I drug-drug interaction study in healthy volunteers was performed to evaluate the impact of co-administering rifampicin (a strong CYP3A4 inducer) and itraconazole (a strong CYP3A4 inhibitor) on the pharmacokinetics of SH-1028. The in vitro experiments showed that SH-1028 was mainly metabolized by CYP3A4. The activities of CYP1A2, 2B6, 2C19, 2D6 and 3A4 enzymes were slightly inhibited in vitro with SH-1028. SH-1028 has no obvious induction effect on CYP1A2 and CYP2B6 activities, but has potential induction effect on CYP3A4 mRNA expression. However, SH-1028 may not induce or inhibit human CYPs significantly at the clinically expected dose (200 mg). The geometric mean ratios of pharmacokinetic parameters and their corresponding 90% confidence intervals for SH-1028 in combination and alone did not fall within the range of 80-125%. It is speculated that itraconazole and rifampicin affect the metabolism of SH-1028. In the clinical application of SH-1028, special attention should be paid to the interaction between SH-1028 and drugs or foods that affect the activity of CYP3A4. (Clinical trial registration number: CTR20210558).
Collapse
Grants
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- BY51201313, China 512 Talent Fund" of Bengbu Medical College
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
- 2021043 Research and development project commissioned by Nanjing Sanhome Pharmaceutical Co., Ltd
Collapse
Affiliation(s)
- Xiaoli Li
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
| | - Yuyan Liu
- School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China
| | - Minhui Zhu
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
| | - Cuixia He
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
| | - Yuanyuan Xu
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
| | - Jiaxiang Ding
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Public Foundation, Bengbu Medical College, 233030, Bengbu, China
| | - Ying Wang
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
| | - Rongfang Shan
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
| | - Bingyan Liu
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
| | - Yuzhou Ding
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
| | - Jing Xie
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
| | - Huan Zhou
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China
- School of Public Foundation, Bengbu Medical College, 233030, Bengbu, China
| | - Zhiqiang Wang
- Nanjing Sanhome Pharmaceutical Co., Ltd, 210000, Nanjing, China
| | - Yuanyuan Liu
- Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, 233009, Bengbu, China.
- School of Pharmacy, Bengbu Medical College, 233030, Bengbu, China.
| |
Collapse
|
16
|
Andrady AL, Heikkilä AM, Pandey KK, Bruckman LS, White CC, Zhu M, Zhu L. Effects of UV radiation on natural and synthetic materials. Photochem Photobiol Sci 2023; 22:1177-1202. [PMID: 37039962 PMCID: PMC10088630 DOI: 10.1007/s43630-023-00377-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2023] [Accepted: 01/13/2023] [Indexed: 04/12/2023]
Abstract
The deleterious effects of solar ultraviolet (UV) radiation on construction materials, especially wood and plastics, and the consequent impacts on their useful lifetimes, are well documented in scientific literature. Any future increase in solar UV radiation and ambient temperature due to climate change will therefore shorten service lifetimes of materials, which will require higher levels of stabilisation or other interventions to maintain their lifetimes at the present levels. The implementation of the Montreal Protocol and its amendments on substances that deplete the ozone layer, controls the solar UV-B radiation received on Earth. This current quadrennial assessment provides a comprehensive update on the deleterious effects of solar UV radiation on the durability of natural and synthetic materials, as well as recent innovations in better stabilising of materials against solar UV radiation-induced damage. Pertinent emerging technologies for wood and plastics used in construction, composite materials used in construction, textile fibres, comfort fabric, and photovoltaic materials, are addressed in detail. Also addressed are the trends in technology designed to increase sustainability via replacing toxic, unsustainable, legacy additives with 'greener' benign substitutes that may indirectly affect the UV stability of the redesigned materials. An emerging class of efficient photostabilisers are the nanoscale particles that include oxide fillers and nanocarbons used in high-performance composites, which provide good UV stability to materials. They also allow the design of UV-shielding fabric materials with impressive UV protection factors. An emerging environmental issue related to the photodegradation of plastics is the generation of ubiquitous micro-scale particles from plastic litter exposed to solar UV radiation.
Collapse
Affiliation(s)
- A. L. Andrady
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC USA
| | | | - K. K. Pandey
- Indian Academy of Wood Science, Bangalore, India
| | - L. S. Bruckman
- Department of Materials Science and Engineering, Case Western Reserve University, Cleveland, OH USA
| | | | - M. Zhu
- College of Materials Science and Engineering, Donghua University, Shanghai, China
| | - L. Zhu
- State Key Laboratory for Modification of Chemical Fibres and Polymer Materials, Donghua University, Shanghai, China
| |
Collapse
|
17
|
Wang Y, Tang B, Xie J, Wang X, Ren P, Wu G, He C, Zhu M, Su Y, Ding J, Xu Y, Fan L, Ge Q, Ding Y, Zhu J, Liu B, Shan R, Zhou H. Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study. BMC Pharmacol Toxicol 2023; 24:10. [PMID: 36810140 PMCID: PMC9942619 DOI: 10.1186/s40360-023-00646-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2022] [Accepted: 01/23/2023] [Indexed: 02/23/2023] Open
Abstract
PURPOSE The study was aimed at evaluating the bioequivalence and safety of oseltamivir phosphate for suspension, provided by Shenzhen Beimei Pharmaceutical Co. Ltd. and manufactured by Hetero Labs Limited, and the reference product TAMIFLU® in healthy Chinese subjects. METHODS A single-dose, randomized, two-phase, self-crossed model was adopted. Among 80 healthy subjects, 40 subjects in the fasting group and 40 subjects in the fed group. Subjects in the fasting group were randomized into two sequences according to the proportion of 1:1, each given 75 mg/12.5 mL of Oseltamivir Phosphate for Suspension or TAMIFLU®, and cross-administered after 7 days. Postprandial group is the same as fasting group. RESULTS The Tmax of TAMIFLU® and Oseltamivir Phosphate for Suspension in the fasting group were 1.50 h and 1.25 h, which in the fed group were both 1.25 h. Geometrically adjusted mean ratios of the PK parameters of Oseltamivir Phosphate for Suspension along with TAMIFLU® under fasting and postprandial conditions were in the range of 80.00-125.00% at the 90% confidence interval (CI). The 90% CI of Cmax, AUC0-t, AUC0-∞ for fasting group and postprandial group were (92.39,106.50), (94.26,100.67), (94.32,100.89) and (93.61,105.83),(95.64,100.19),(96.06,102.66). Among the subjects on medication, a total of 18 subjects reported 27 adverse events, all of which were treatment-emergent adverse events (TEAEs), six of these TEAEs were rated as grade 2 in severity and the rest were as grade 1. The number of TEAEs in the test product and the reference product were 14,13 respectively. CONCLUSION Two Oseltamivir phosphate for suspensions are safe and bioequivalent.
Collapse
Affiliation(s)
- Ying Wang
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Bangzhong Tang
- Shenzhen Beimei Pharmaceutical Co, Ltd, Shenzhen, Guangdong, China
| | - Jing Xie
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Xiaoqin Wang
- Shenzhen Beimei Pharmaceutical Co, Ltd, Shenzhen, Guangdong, China
| | - Peng Ren
- Shenzhen Beimei Pharmaceutical Co, Ltd, Shenzhen, Guangdong, China
| | - Guangmei Wu
- Shenzhen Beimei Pharmaceutical Co, Ltd, Shenzhen, Guangdong, China
| | - Cuixia He
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Minhui Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Yue Su
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China
| | - Jiaxiang Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China
| | - Yuanyuan Xu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Ling Fan
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Qin Ge
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Yuzhou Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Juan Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Bingyan Liu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Rongfang Shan
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China
| | - Huan Zhou
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China. .,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, China. .,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, China.
| |
Collapse
|
18
|
Song Y, Zang Y, Chen Z, Li J, Zhu M, Zhu H, Chu W, Liu G, Shen C. The application of the Limberg flap repair technique in the surgical treatment of pilonidal sinus disease. Int Wound J 2023. [PMID: 36802113 DOI: 10.1111/iwj.14105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2022] [Revised: 01/10/2023] [Accepted: 01/16/2023] [Indexed: 02/22/2023] Open
Abstract
Pilonidal sinus disease (PNSD) challenged surgeons for decades. Limberg flap repair (LFR) is a common treatment for PNSD. The purpose of this study was to observe the effect and risk factors of LFR in PNSD. A retrospective study was conducted on the PNSD patients who visited two medical centers and four departments in the People's Liberation Army General Hospital and were taking LFR treatment between 2016 and 2022. The risk factors, the effect of the operation, and complications were observed. The effects of known risk factors on the surgical results were compared. There were 37 PNSD patients: male/female ratio of 35:2, average age: 25.1 ± 7.9 years. Average BMI: 25.2 ± 4.0 kg/m2 , average wound healing time: 15.4 ± 3.4 days. 30 patients (81.0%) healed in stage one and 7 (16.3%) had postoperative complications. Only 1 patient (2.7%) had a recurrence while others were healed after dressing-changing. There was no significant difference in age, BMI, preoperative debridement history, preoperative sinus classification, Wound area, Negative pressure drainage tube, prone time (<3d) and treatment effect. Squat defecate and premature defecation were associated with treatment effect, and they were independent predictors of treatment effect in the multivariate analysis. LFR has a stable therapeutic outcome. Compared with other skin flaps, the therapeutic effect of this flap is not significantly different, but the design is simple and is not affected by the known risk factors before operation. However, it is necessary to avoid the influence of two independent risk factors, squatting defecation and premature defecation, on the therapeutic effect.
Collapse
Affiliation(s)
- Yaoyao Song
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yu Zang
- Department of General surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Zequn Chen
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Jianjun Li
- Department of General surgery, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Minhui Zhu
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Hongjuan Zhu
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Wanli Chu
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Gang Liu
- Department of General surgery, Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Chuan'an Shen
- Department of Burn and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, China
| |
Collapse
|
19
|
Geerardyn A, Zhu M, Wu P, O'Malley J, Nadol JB, Liberman MC, Nakajima HH, Verhaert N, Quesnel AM. Three-dimensional quantification of fibrosis and ossification after cochlear implantation via virtual re-sectioning: Potential implications for residual hearing. Hear Res 2023; 428:108681. [PMID: 36584546 PMCID: PMC10942756 DOI: 10.1016/j.heares.2022.108681] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 12/13/2022] [Accepted: 12/18/2022] [Indexed: 12/24/2022]
Abstract
Hearing preservation may be achieved initially in the majority of patients after cochlear implantation, however, a significant proportion of these patients experience delayed hearing loss months or years later. A prior histological report in a case of delayed hearing loss suggested a potential cochlear mechanical origin of this hearing loss due to tissue fibrosis, and older case series highlight the frequent findings of post-implantation fibrosis and neoosteogenesis though without a focus on the impact on residual hearing. Here we present the largest series (N = 20) of 3-dimensionally reconstructed cochleae based on digitally scanned histologic sections from patients who were implanted during their lifetime. All patients were implanted with multichannel electrodes via a cochleostomy or an extended round window insertion. A quantified analysis of intracochlear tissue formation was carried out via virtual re-sectioning orthogonal to the cochlear spiral. Intracochlear tissue formation was present in every case. On average 33% (SD 14%) of the total cochlear volume was occupied by new tissue formation, consisting of 26% (SD 12%) fibrous and 7% (SD 6%) bony tissue. The round window was completely covered by fibro-osseous tissue in 85% of cases and was associated with an obstruction of the cochlear aqueduct in 100%. The basal part of the basilar membrane was at least partially abutted by the electrode or new tissue formation in every case, while the apical region, corresponding with a characteristic frequency of < 500 Hz, appeared normal in 89%. This quantitative analysis shows that after cochlear implantation via extended round window or cochleostomy, intracochlear fibrosis and neoossification are present in all cases at anatomical locations that could impact normal inner ear mechanics.
Collapse
Affiliation(s)
- A Geerardyn
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA; ExpORL, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium
| | - M Zhu
- Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA
| | - P Wu
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Eaton Peabody Laboratories, Massachusetts Eye and Ear, Boston, MA, USA
| | - J O'Malley
- Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA
| | - J B Nadol
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA
| | - M C Liberman
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA; Eaton Peabody Laboratories, Massachusetts Eye and Ear, Boston, MA, USA
| | - H H Nakajima
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Eaton Peabody Laboratories, Massachusetts Eye and Ear, Boston, MA, USA
| | - N Verhaert
- ExpORL, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium
| | - A M Quesnel
- Department of Otolaryngology - Head & Neck Surgery, Harvard Medical School, Boston, MA, USA; Otopathology Laboratory, Massachusetts Eye and Ear, Boston, MA, USA.
| |
Collapse
|
20
|
Guo F, Liu B, Li X, Wang H, Zhu X, Su Y, He C, Zhu M, Ding J, Xu Y, Zhao X, Wang Y, Shan R, Zhu J, Xie J, Ge Q, Fan L, Ding Y, Xie Y, Zhang C, Li H, Wang H, Zhou H. Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [ 14C] SHC014748M in healthy Chinese subjects following oral administration. Cancer Chemother Pharmacol 2023; 91:143-156. [PMID: 36572783 DOI: 10.1007/s00280-022-04493-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 11/15/2022] [Indexed: 12/28/2022]
Abstract
PURPOSE SHC014748M is a potent, novel selective PI3Kδ isoform inhibitor and is proposed for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. This study investigated the pharmacokinetics, mass balance, metabolism and excretion of SHC014748M in Chinese male subjects following a single oral dose of 150 mg (100 μCi) [14C] SHC014748M. METHODS Six healthy Chinese male subjects administrated an oral suspension of 150 mg (100 μCi) [14C] SHC014748M and the samples of blood, urine and feces were collected for measuring. Liquid chromatography-tandem mass spectrometry and liquid scintillation counter were utilized to obtain mass balance and the pharmacokinetic data. RESULTS The median Tmax for [14C]-radioactivity was 1.6 ± 0.5 h after the oral administration of [14C] SHC014748M and the mean Cmax was 3863 ± 354 ng Eq./mL in plasma, while the mean Cmax, t1/2 values and AUC0-∞ values for total radioactivity in whole blood were 2466 ± 518 ng Eq./mL, 32.2 ± 30.5 h and 66,236 ± 44,232 h * ng Eq./mL, respectively. Fecal excretion was proposed as the predominant elimination route, accounting for a mean of 90.68 ± 11.38% of the administered dose, whereas the mean urine excretion was 6.00 ± 1.48% within 336 h post-dose. The proposed major metabolic pathway of [14C] SHC014748M in the human body were as follows: (I) monooxidation, (II) glucuronide acid conjugation, and (III) monoxide-hydrogenation. CONCLUSIONS SHC014748M was absorbed, metabolized and excreted with unchanged SHC014748M as its main circulating component in plasma following oral administration. In addition, it was speculated that fecal excretion was the principal excretion pathway; meanwhile, monohydroxy, glucuronide conjugation, oxygen, and hydrogenation were the major clearance pathways of SHC014748M through urine and/or feces. TRIAL REGISTRATION The trial registration number: CTR20202505.
Collapse
Affiliation(s)
- Fei Guo
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,Department of Medical Imaging Diagnosis, School of Medical Imaging, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Bingyan Liu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Xiaoli Li
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Haidong Wang
- Department of Pharmacy, The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People's Hospital of Lianyungang, Lianyungang, 222000, People's Republic of China
| | - Xingyu Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Yue Su
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Cuixia He
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Minhui Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Jiaxiang Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Yuanyuan Xu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Xiangdi Zhao
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Ying Wang
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Rongfang Shan
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Juan Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Jing Xie
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Qin Ge
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Ling Fan
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Yuzhou Ding
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Yunqiu Xie
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Chaoyang Zhang
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Hongtao Li
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China
| | - Hongju Wang
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
| | - Huan Zhou
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China. .,School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, People's Republic of China. .,School of Public Foundation, Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
| |
Collapse
|
21
|
Zhu M, Yang X, Huang Y, Wang Z, Xiong Z. Serum SIRT6 Levels Are Associated with Frailty in Older Adults. J Nutr Health Aging 2023; 27:719-725. [PMID: 37754211 DOI: 10.1007/s12603-023-1969-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Accepted: 07/23/2023] [Indexed: 09/28/2023]
Abstract
OBJECTIVES Frailty is one of the major health problems facing aging societies worldwide. We investigated the association between serum SIRT6 and frailty in older adults. DESIGN Cross-sectional analysis of associations of serum SIRT6 and frailty in older people. SETTING Enrolled community-dwelling and hospital outpatient clinic adults older than 65 years old in Wuhan City, Hubei Province, China. PARTICIPANTS A total of 540 community-dwelling older adults (age ≥ 65 years) in Wuhan were included in the study. MEASURES We used Frailty Phenotype criteria for classifying participants based on their frailty status. Serum SIRT6 was measured using an ELISA kit. RESULTS A total of 540 older adults were included in this cross-sectional study. Serum SIRT6 was lower in the slowness group (7.23±1.81 vs 5.89±1.74, p<0.001), weakness group (6.87±1.88 vs 5.68±1.64, p<0.001), and exhaustion group (6.73±1.90 vs 5.88±1.74, p<0.001) compare with the normal group. ROC curves were used to assess the efficiency of SIRT6 in predicting frailty in older adults. The AUC for SIRT6 was 0.792 (95% CI: 0.7514 to 0.8325), with the highest sensitivity of 68.0% and the specificity of 91.9%, and the optimal critical value of 4.65ng/ml according to Youden's index. Multivariate logistic regression analysis showed that serum SIRT6 level was independently associated with frailty in older people. CONCLUSION In conclusion, serum SIRT6 was decreased in frailty compared with robust older adults. A decreased serum SIRT6 was independently associated with an increased risk of frailty. SIRT6 may be a potential target for the treatment of patients with frailty.
Collapse
Affiliation(s)
- M Zhu
- Zhifan Xiong, Division of Gastroenterology, Institute of Geriatric Medicine, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, 39 Lake Road, East Lake Ecological Science, Wuhan 430077, Hubei, China,
| | | | | | | | | |
Collapse
|
22
|
Du L, Zhu G, Xu Y, Han B, Wang Y, Zhu M, Meng Y, Chen H, Yu Z. Integrated radiochemotherapy study of ZIF-8 coated with osteosarcoma-platelet hybrid membranes for the delivery of Dbait and Adriamycin. Front Bioeng Biotechnol 2023; 11:1147064. [PMID: 36873373 PMCID: PMC9981937 DOI: 10.3389/fbioe.2023.1147064] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Accepted: 02/09/2023] [Indexed: 02/19/2023] Open
Abstract
Introduction: The toxic side effects of systemic high-dose chemotherapy and poor sensitivity to radiotherapy hinder the survival rate of patients with osteosarcoma (OS). Nanotechnology offers new solutions for OS treatment; however, conventional nanocarriers suffer from inadequate targeting of tumors and short in vivo circulation time. Methods: Here, we designed a novel drug delivery system, [Dbait-ADM@ZIF-8]OPM, which uses OS-platelet hybrid membranes to encapsulate nanocarriers, to enhance the targeting and circulation time of nanocarriers, thereby enabling high enrichment of the nanocarriers in OS sites. Results: In the tumor microenvironment, the pH-sensitive nanocarrier, which is the metal-organic framework ZIF-8, dissociates to release radiosensitizer Dbait and the classical chemotherapeutic agent Adriamycin for the integrated treatment of OS via radiotherapy and chemotherapy. Benefiting from the excellent targeting ability of the hybrid membrane and the outstanding drug loading capacity of the nanocarrier, [Dbait-ADM@ZIF-8]OPM showed potent anti-tumor effects in tumor-bearing mice with almost no significant biotoxicity. Conclusion: Overall, this project is a successful exploration of the combination of radiotherapy and chemotherapy of OS treatment. Our findings solve the problems of the insensitivity of OS to radiotherapy and the toxic side effects of chemotherapy. Furthermore, this study is an expansion of the research of OS nanocarriers and provides new potential treatments for OS.
Collapse
Affiliation(s)
- Longhai Du
- Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, China
| | - Guanghao Zhu
- Department of Otolaryngology, Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Yanlong Xu
- Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, China
| | - Binxu Han
- Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, China
| | - Yu Wang
- Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, China
| | - Minhui Zhu
- Department of Otolaryngology, Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Yingdi Meng
- Department of Otolaryngology, Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Huaiwen Chen
- Department of Otolaryngology, Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China
| | - Zuochong Yu
- Department of Orthopedics, Jinshan Hospital, Fudan University, Shanghai, China
| |
Collapse
|
23
|
Zhang M, Sun J, Zhu M, Sun T, Shi Z, Zhang L, Wang X, Song Y, Ye X, Deng Y, Chu W, Shen C. Within-patient randomised clinical trial exploring the development of microskin implantation in the treatment of pressure ulcers. Int Wound J 2022. [PMID: 36575064 DOI: 10.1111/iwj.14051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 11/30/2022] [Accepted: 12/04/2022] [Indexed: 12/29/2022] Open
Abstract
Pressure injury often seriously affects the life quality of aged patients, especially the long-term bedridden casualties. Widely adopted by different disciplines, negative pressure suction has its role in pressure injury. Microskin implantation has been demonstrated powerful in increasing the expansion ratio of donor area-derived skin and accelerating wound healing by forming "skin islands". The study was designed to evaluate the efficacy and safety of additional use of bedside microskin implantation in the palliative care of pressure injury of aged patients who cannot tolerate surgical treatment as a supplement for standard negative pressure suction. An open-label within-patient RCT was conducted in aged patients with pressure injury. Sixteen patients were enrolled. After granulation tissues formed, half of a pressure injury was randomised to receive the negative pressure suction as the control group, and the other half exposed to additional bedside microskin implantation as the experimental group. Efficacy was evaluated within 1 month after treatment, and the primary endpoints included the wound healing rate and pressure ulcer scale for healing (PUSH) scores. The secondary outcomes included survival rate of implanted microskin, pain intensity assessment, satisfaction surveys from patients or their family, and pressure ulcer healing complications. Sixteen patients completed the study. After 14 days of operation, 5.63 ± 1.78 out of 10 pieces of implanted microskin survived and formed neonatal epithelium. The wound healing rates of the control group and the experimental group at 1 month were (26.17 ± 9.03%) and (35.95 ± 16.02%), respectively (P < .01). The mean PUSH score before the surgery was 12.38 ± 2.23. At 1 month after surgery, the mean difference of PUSH score from baseline was 2.13 ± 0.96 in the control group and 2.81 ± 0.83 in the experimental group (P < .01). The treatment of microskin implantation did not cause additional pain or complications to the patients. Accompanied by a better ulcer status, the majority of patients or their guardians have a high degree of acceptance towards the microskin implantation. Bedside microskin implantation could accelerate wound healing with lower PUSH scores. As a complementary palliative treatment, supplementary microskin implantation is effective and well tolerated.
Collapse
Affiliation(s)
- Ming Zhang
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Jiachen Sun
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Minhui Zhu
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Tianjun Sun
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Zhiyuan Shi
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Lu Zhang
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Xingtong Wang
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Yaoyao Song
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Xiangbo Ye
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Yuanxin Deng
- Department of Critical Care Medicine, Peking University Cancer Hospital, Beijing, People's Republic of China
| | - Wanli Chu
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Chuanan Shen
- Department of Burns and Plastic Surgery, Fourth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China
| |
Collapse
|
24
|
Wang H, Wei XX, Ma ZM, Ji MM, Huang YQ, Zhang J, Zhu M, Dai JC, Jin GF, Ma HX, Hu ZB, Shen HB. [Mediation effect of smoking and healthy diet score on the association between educational level and the risk of lung cancer incidence]. Zhonghua Liu Xing Bing Xue Za Zhi 2022; 43:1875-1880. [PMID: 36572457 DOI: 10.3760/cma.j.cn112338-20220628-00572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Objective: To evaluate the possible mediation effect of smoking and healthy diet score on the association between educational level and the risk of lung cancer incidence. Methods: After excluding individuals with missing educational levels and cancer information at baseline, 446 772 participants in the UK Biobank (UKB) prospective cohort study were included. Cox regression models were used to investigate the associations of educational level and smoking and healthy diet score with the incidence of lung cancer. Mediating effect analysis was conducted to analyze the mediating effect of smoking and healthy diet score on the correlation between educational level and lung cancer. Results: During a median follow-up of 7.13 years, 1 994 new- onset lung cancer cases were observed. Per 1 standard deviation (5 years) increase in educational level was associated with a 12% lower risk of lung cancer (HR=0.88, 95%CI: 0.84-0.92). The corresponding level 1-5 in the International Standard Classification for Education (ISCED) were mapped to UKB self-report highest qualification to estimate the educational level. A higher rank means a higher educational level. Compared with level ISCED-1, the HR(95%CI) of level ISCED-2, ISCED-3, ISCED-4 and ISCED-5 were respectively 0.83 (0.72-0.94), 0.67 (0.53-0.85), 0.76 (0.65-0.89) and 0.72 (0.64-0.80) for lung cancer. Education years were negatively correlated with smoking, with β coefficients (95%CI) being -0.079 (-0.081- -0.077), but positively correlated with healthy diet score (β=0.042, 95%CI: 0.039-0.045). Analysis of mediating effect indicated that the association of educational level with lung cancer risk was mediated by smoking and healthy diet score, the proportions of mediating effect were 38.952% (95%CI: 31.802%-51.659%) and 1.784% (95%CI: 0.405%-3.713%), respectively. Conclusion: Smoking and healthy diet score might mediate the effect of educational level on the incidence of lung cancer, indicating that improving the level of education can reduce the risk of lung cancer by changing lifestyles such as smoking and diet.
Collapse
Affiliation(s)
- H Wang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - X X Wei
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - Z M Ma
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - M M Ji
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - Y Q Huang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - J Zhang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - M Zhu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| | - J C Dai
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| | - G F Jin
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| | - H X Ma
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| | - Z B Hu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| | - H B Shen
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
| |
Collapse
|
25
|
Wang L, Huang ZM, Jiang YY, Zhu M, Zhang N, Xiong FB, Zou HZ, Xu XH. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:1767-1773. [PMID: 36536564 DOI: 10.3760/cma.j.cn112150-20220314-00233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Objective: To investigate the value of stool-based methylated SDC2 test in physical examination population for the screening of colorectal neoplasms. Methods: Using the prospective cohort study method, from December 2020 to November 2021, 2 107 participants from the First People's Hospital of Xiushui County, Jiangxi Province were enrolled, consisted of 1 012 males and 1 094 females, aged 20-90 years with the median age of 49 years old. Fresh stool samples were collected and SDC2 DNA methylation tests were carried out as the primary screening method. The participants with positive results were recommended to undergo colonoscopy, and those who were negative were followed up by telephone. The positive rate of screening, the compliance of colonoscopy, and the detection of colorectal lesions were analyzed by chi-square test. Combined the follow-up results of negative subjects, the value of SDC2 DNA methylation test for the screening of colorectal neoplasms was evaluated. Results: Among the 2 107 participants, 2 106 completed the SDC2 methylation test. 113 participants (5.4%) were positive. The positive rate of primary screening increased with age significantly (χ2=32.135, P<0.001). Out of 113 cases, 72 (63.7%) underwent colonoscopy examinations. Finally, 3 (4.2%) cases of colorectal cancer, 12 (16.7%) cases of advanced adenoma, 31 (43.1%) cases of non-advanced adenoma, and 16 (22.2%) cases of non-adenomatous polyp were detected. The positive predictive value (PPV) of stool-based SDC2 DNA methylation test for intestinal lesions and colorectal neoplasms were 86.1% and 63.9%, respectively. Among the 1 374 follow-up participants, the negative predictive value (NPV) of this test for intestinal lesions and colorectal neoplasms were 97.7% and 99.4%, respectively. Conclusion: Primary stool-based SDC2 DNA methylation test and subsequent colonoscopy examination can effectively find colorectal neoplasms. This strategy may be a potential tool for the screening of colorectal neoplasms in general risk population.
Collapse
Affiliation(s)
- L Wang
- Gastroenterology Department, The First People's Hospital of Xiushui County, Jiujiang 332400, China
| | - Z M Huang
- Health Management Center, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y Y Jiang
- Gastroenterology Department, The First People's Hospital of Xiushui County, Jiujiang 332400, China
| | - M Zhu
- Gastroenterology Department, The First People's Hospital of Xiushui County, Jiujiang 332400, China
| | - N Zhang
- Gastroenterology Department, The First People's Hospital of Xiushui County, Jiujiang 332400, China
| | - F B Xiong
- Gastroenterology Department, The First Hospital of Nanchang, Nanchang 330008, China
| | - H Z Zou
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China
| | - X H Xu
- Gastroenterology Department, The First People's Hospital of Xiushui County, Jiujiang 332400, China
| |
Collapse
|
26
|
Moore K, Bouberhan S, Hamilton E, Liu J, O'Cearbhaill R, O'Malley D, Papadimitriou K, Schröder D, Van Nieuwenhuysen E, Yoo SY, Peterman M, Goncalves P, Schmidt T, Zhu M, Lowy I, Uldrick T, Miller E. 197TiP First-in-human (FIH) phase I/II study of ubamatamab, a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer (OC). Immuno-Oncology and Technology 2022. [DOI: 10.1016/j.iotech.2022.100309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
27
|
Xie J, Fan X, Su Y, Zhou H, Cao S, Zhu X, Zhu M, He C, Wang Y, Fan L, Ge Q, Zhu J, Liu B, Chen X, Xie Y, Ma L, Liu Y, Chen J, Wang H, Li Z. Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects. Clin Pharmacol Drug Dev 2022; 11:1273-1283. [PMID: 35844038 PMCID: PMC9796261 DOI: 10.1002/cpdd.1136] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Accepted: 06/06/2022] [Indexed: 01/27/2023]
Abstract
Telitacicept, an injectable recombinant human B-lymphocyte stimulating factor receptor-antibody fusion protein, is a new dual B lymphocyte stimulator (BLyS)/APRIL (a proliferation-inducing ligand) inhibitor that effectively blocks proliferation of B lymphocytes. This study evaluates the pharmacokinetic characteristics, tolerability, and safety of a single subcutaneous injection of various doses (80, 160, and 240 mg) of telitacicept in healthy Chinese subjects. This trial is a single-center, randomized, open-label phase I clinical study that includes three dose groups (80, 160, and 240 mg) with 12 subjects in each dose group. The subjects were randomly assigned to different dose groups in a 1:1:1 ratio for a single subcutaneous administration trial. After a single dose, the maximum serum concentration (Cmax ) of total and free telitacicept was reached within 0.5-1 days. The elimination half-lives of total and free telitacicept at doses of 80-240 mg were 10.9-11.9 days and 11-12.5 days, respectively. The formation and elimination of the BLyS-telitacicept complex were much slower; the median time to Cmax was 15-57 days and was significantly prolonged with increasing dose. Only two of the 36 healthy subjects had positive antidrug antibodies with antibody titers of 1:15. The severity of adverse events was mild or moderate, and no higher treatment-emergent adverse events were reported. In conclusion, total telitacicept within a dose range of 80-240 mg and free telitacicept within a dose range of 160-240 mg had linear pharmacokinetic characteristics.
Collapse
Affiliation(s)
- Jing Xie
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Xiaoyun Fan
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,The First Affiliated Hospital of Jinan UniversityGuangzhouGuangdongChina
| | - Yue Su
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,School of Public FoundationBengbu Medical CollegeBengbuAnhuiChina
| | - Huan Zhou
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,School of Public FoundationBengbu Medical CollegeBengbuAnhuiChina,School of PharmacyBengbu Medical CollegeBengbuAnhuiChina
| | - Shugang Cao
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,The Affiliated Hefei Hospital of Anhui Medical UniversityHefeiAnhuiChina
| | - Xingyu Zhu
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,School of PharmacyBengbu Medical CollegeBengbuAnhuiChina
| | - Minhui Zhu
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,School of PharmacyBengbu Medical CollegeBengbuAnhuiChina
| | - Cuixia He
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,School of PharmacyBengbu Medical CollegeBengbuAnhuiChina
| | - Ying Wang
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Ling Fan
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Qin Ge
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Juan Zhu
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Bingyan Liu
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Xiao Chen
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Yunqiu Xie
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Ling Ma
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Yuanyuan Liu
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Juan Chen
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Huaxue Wang
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina
| | - Zhijun Li
- National Institute of Clinical Drug TrialsThe First Affiliated Hospital of Bengbu Medical CollegeBengbuAnhuiChina,The First Affiliated Hospital of Jinan UniversityGuangzhouGuangdongChina
| |
Collapse
|
28
|
Zhu M, Chen YZ, Ou JZ, Li Z, Huang S, Hu XY, Ju Y, Tian ZW, Niu Z. [Effects and mechanism of water-soluble chitosan hydrogel on infected full-thickness skin defect wounds in diabetic mice]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2022; 38:923-931. [PMID: 36299203 DOI: 10.3760/cma.j.cn501225-20220507-00175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To explore the effects and mechanism of water-soluble chitosan hydrogel on infected full-thickness skin defect wounds in diabetic mice. Methods: The experimental research method was adopted. The control hydrogel composed of polyvinyl alcohol and gelatin, and the water-soluble chitosan hydrogel composed of the aforementioned two materials and water-soluble chitosan were prepared by the cyclic freeze-thaw method. The fluidity of the two dressings in test tube before and after the first freeze-thawing was generally observed, and the difference in appearance of the final state of two dressings in 12-well plates were compared. According to random number table (the same grouping method below), the cell strains of L929 and HaCaT were both divided into water-soluble chitosan hydrogel group and control hydrogel group, respectively. After adding corresponding dressings and culturing for 24 h, the cell proliferation activity was measured using cell counting kit 8. Rabbit blood erythrocyte suspensions were divided into normal saline group, polyethylene glycol octyl phenyl ether (Triton X-100) group, water-soluble chitosan hydrogel group, and control hydrogel group, which were treated accordingly and incubated for 1 hour, and then the hemolysis degree of erythrocyte was detected by a microplate reader. Twenty-four female db/db mice aged 11-14 weeks were selected, and full-thickness skin defect wounds on their backs were inflicted and inoculated with the methicillin-resistant Staphylococcus aureus (MRSA), 72 h later, the mice were divided into blank control group, sulfadiazine silver hydrogel group, control hydrogel group, and water-soluble chitosan hydrogel group, which were treated accordingly. On post injury day (PID) 0 (immediately), 7, 14, and 21, the healing of the wound was observed. On PID 14 and 21, the wound healing rate was calculated. On PID 14, MRSA concentration in wounds was determined. On PID 21, the wounds were histologically analyzed by hematoxylin and eosin staining; the expression of CD31 in the wounds was detected by immunofluorescence method, and its positive percentage was calculated. Raw264.7 cells were taken and divided into interleukin-4 (IL-4) group, blank control group, control hydrogel group, and water-soluble chitosan hydrogel group, which were treated accordingly. At 48 h of culture, the percentages of CD206 positive cells were detected by flow cytometry. The number of samples was all 3. Data were statistically analyzed with independent sample t test, one-way analysis of variance, analysis of variance for repeated measurement, least significant difference test, and Dunnett T3 test. Results: Two dressings in test tube had certain fluidity before freeze-thawing and formed semi-solid gels after freeze-thawing for once. The final forms of two dressings in 12-well plates were basically stable and translucent sheets, with little difference in transparency. At 24 h of culture, the cell proliferation activities of L929 and HaCaT in water-soluble chitosan hydrogel group were significantly higher than those in control hydrogel group (with t values of 6.37 and 7.50, respectively, P<0.01). At 1 h of incubation, the hemolysis degree of erythrocyte in water-soluble chitosan hydrogel group was significantly lower than that in Triton X-100 group (P<0.01), but similar to that in normal saline group and control hydrogel group (P>0.05). On PID 0, the traumatic conditions of mice in the 4 groups were similar. On PID 7, more yellowish exudates were observed inside the wound in blank control group and control hydrogel group, while a small amount of exudates were observed in the wound in sulfadiazine silver hydrogel group and water-soluble chitosan hydrogel group. On PID 14, the wounds in blank control group and control hydrogel group were dry and crusted without obvious epithelial coverage; in sulfadiazine silver hydrogel group, the scabs fell off and purulent exudate was visible on the wound; in water-soluble chitosan hydrogel group, the base of wound was light red and obvious epithelial coverage could be observed on the wound. On PID 14, the wound healing rate in water-soluble chitosan hydrogel group was significantly higher than that in the other 3 groups (all P<0.01). On PID 21, the wound in water-soluble chitosan hydrogel group was completely closed, while the wounds in the other 3 groups were not completely healed; the wound healing rate in water-soluble chitosan hydrogel group was significantly higher than that in the other 3 groups (all P<0.01). On PID 14, the concentration of MRSA in the wound in water-soluble chitosan hydrogel group was significantly lower than that in blank control group (P<0.01), but similar to that in control hydrogel group and sulfadiazine silver hydrogel group (P>0.05). On PID 21, the new epidermis was severely damaged in blank control group; the epidermis on the wound in control hydrogel group also had a large area of defect; complete new epidermis had not yet being formed on the wound in sulfadiazine silver hydrogel group; the wound in water-soluble chitosan hydrogel group was not only completely covered by the new epidermis, the basal cells of the new epidermis were also regularly aligned. On PID 21, the percentage of CD31 positivity in the wound in water-soluble chitosan hydrogel group was (2.19±0.35)%, which was significantly higher than (0.18±0.05)% in blank control group, (0.23±0.06)% in control hydrogel group, and (0.62±0.25)% in sulfadiazine silver hydrogel group, all P<0.01. At 48 h of culture, the percentage of CD206 positive Raw264.7 cells in water-soluble chitosan hydrogel group was lower than that in IL-4 group (P>0.01) but significantly higher than that in blank control group and control hydrogel group (P<0.05 or P<0.01). Conclusions: The water-soluble chitosan hydrogel has good biosafety and can induce higher level of macrophage M2 polarization than control hydrogel without water-soluble chitosan, so it can enhance the repair effect of MRSA-infected full-thickness skin defect wounds in diabetic mice and promote rapid wound healing.
Collapse
Affiliation(s)
- M Zhu
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - Y Z Chen
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - J Z Ou
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - Z Li
- Research Center for Wound Repair and Tissue Regeneration, Medical Innovation Research Department, the PLA General Hospital, Beijing 100048, China
| | - S Huang
- Research Center for Wound Repair and Tissue Regeneration, Medical Innovation Research Department, the PLA General Hospital, Beijing 100048, China
| | - X Y Hu
- Department of Burns, Beijing Jishuitan Hospital, Beijing 100035, China
| | - Y Ju
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - Z W Tian
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - Zhongwei Niu
- Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| |
Collapse
|
29
|
Ge S, Zhu X, Xu Q, Wang J, An C, Hu Y, Yang F, Wang X, Yang Y, Chen S, Jin R, Li H, Peng X, Liu Y, Xu J, Zhu M, Shuai Z. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. Front Pharmacol 2022; 13:957660. [PMID: 36210838 PMCID: PMC9545605 DOI: 10.3389/fphar.2022.957660] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 09/05/2022] [Indexed: 11/22/2022] Open
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of systemic autoimmune diseases, which is typified by inflammatory necrosis predominantly affecting the small vessels and often accompanied by positive ANCA. Clinically, AAV primarily includes microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA). It has been found that in AAV pathogenesis, both innate and adaptive immunity are related to neutrophil function mutually. Many proteins, such as myeloperoxidase (MPO) and proteinase 3 (PR3), in neutrophil cytoplasm lead to the production of proteins such as MPO-ANCA and PR3-ANCA by activating adaptive immunity. In addition, through the process of neutrophil extracellular trap (NET) formation, activation of an alternative complement pathway and the respiratory burst can stimulate the neutrophils close to vascular endothelial cells and will participate the vessel inflammation. This review aims to reveal the potential mechanisms regulating the association between the neutrophils and various types of AAVs and to emphasize the results of recent findings on these interactions. Moreover, multiple underlying signaling pathways involved in the regulation of neutrophils during AAV processes have also been discussed. The ultimate goal of this review is to identify novel biomarkers and therapeutic targets for AAV management in the future.
Collapse
Affiliation(s)
- Shangqing Ge
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Xingyu Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Qinyao Xu
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Junyan Wang
- Department of Clinical Medical, The Second Clinical Medical College, Anhui Medical University, Hefei, Anhui, China
| | - Cheng An
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Ying Hu
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China
| | - Fan Yang
- Department of Clinical Medical, The First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China
| | - Xinyi Wang
- Department of Clinical Medical, The First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China
| | - Yipin Yang
- Department of Clinical Medical, The First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China
| | - Shuwen Chen
- Department of Clinical Medical, The First Clinical Medical College, Anhui Medical University, Hefei, Anhui, China
| | - Ruimin Jin
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Haiyan Li
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Xinchen Peng
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Yue Liu
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Junnan Xu
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
| | - Minhui Zhu
- National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
| | - Zongwen Shuai
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
- *Correspondence: Zongwen Shuai,
| |
Collapse
|
30
|
Tao Z, Zhu M, Ding J, Jiang D, Yan B. Comparative Analysis of Interaction Mode between MABA and Silver Nanoparticles in the Silver Colloidal Solution. Russ J Phys Chem B 2022. [DOI: 10.1134/s1990793122040339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
31
|
Chen L, Yuan YF, Zhu M, Yin SM, Du PF, Mo CL. Hierarchical hollow superstructure cobalt selenide bird nests for high-performance lithium storage. J Colloid Interface Sci 2022; 627:449-458. [PMID: 35868040 DOI: 10.1016/j.jcis.2022.07.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 07/11/2022] [Accepted: 07/12/2022] [Indexed: 11/26/2022]
Abstract
The inferior cycling performance caused by large volume variation is the main problem that restricts the application of cobalt selenides in lithium-ion batteries. Herein, we synthesize raspberry-like Co-ethylene glycol precursor. It is further selenized into the hierarchical hollow superstructure CoSe2/CoSe bird nests that are assembled by the hollow nanosphere units of CoSe2 and CoSe nanocrystalline. CoSe2/CoSe bird nests achieve excellent cycling performance, high reversible capacity and satisfactory rate capability (1361 mAh/g at 1 A/g after 1000 cycles, 579 mAh/g at 2 A/g after 2000 cycles, 315 mAh/g at 5 A/g after 1000 cycles). Electrochemical kinetics analyses and ex-situ material characterization reveal that the surface capacitive behavior controls the electrochemical reaction, and the composite has low reaction impedance, fast and stable Li+ diffusion, and superior structural stability. The superior lithium storage performance is attributed to the unique superstructure bird nest. Large specific surface area, abundant hierarchical pores and the opening mouth result in high electrochemical activity, which induces high reversible capacity. The small hollow nanosphere units, the sufficiently thick hierarchical porous superstructure shell and the large hollow interior bring about the strong synergistic effect to improve cycling performance. The intimately coupling of CoSe2/CoSe nanocrystalline and the hollow nanosphere units guarantees high conductivity. This work has greatly enriched the understanding of structure design of high-performance cobalt selenide anodes.
Collapse
Affiliation(s)
- L Chen
- College of Machinery and Automation, Zhejiang Sci-Tech University, Hangzhou 310018, China
| | - Y F Yuan
- College of Machinery and Automation, Zhejiang Sci-Tech University, Hangzhou 310018, China.
| | - M Zhu
- College of Machinery and Automation, Zhejiang Sci-Tech University, Hangzhou 310018, China
| | - S M Yin
- College of Machinery and Automation, Zhejiang Sci-Tech University, Hangzhou 310018, China
| | - P F Du
- College of Textile Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China
| | - C L Mo
- College of Machinery and Automation, Zhejiang Sci-Tech University, Hangzhou 310018, China.
| |
Collapse
|
32
|
Lu Z, Gong Z, Wang H, Zhu M, Jiang H, Cao Y. P-382 Decrease of serum estradiol prior to human chorionic gonadotrophin administration have an impact on live birth in IVF/ICSI cycles. Hum Reprod 2022. [DOI: 10.1093/humrep/deac107.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Whether decrease of serum estradiol prior to human chorionic gonadotrophin administration have an impact on live birth in IVF/ICSI cycles?
Summary answer
The E2 change before the day of hCG administration had significant correlation with live birth. The live birth rate decreased with decreasing serum E2 level.
What is known already
The objective of this study was to assess the effects of a decrease of estradiol (E2) levels on the day of human chorionic gonadotrophin (hCG) administration on in vitro fertilization /intracytoplasmic sperm injection (IVF/ICSI) outcomes, including cycles with long, antagonist and micro stimulus protocols.
Study design, size, duration
In this retrospective cohort study, 1303 patients who received IVF/ICSI non-donor treatment were identified. Patients were divided into two groups according to live birth and the characteristics of IVF/ICSI cycles were compared between groups, including baseline infertility parameters, ovarian stimulation characteristics and embryo laboratory manipulation parameters.
Participants/materials, setting, methods
In this retrospective cohort study, 1303 patients who received IVF/ICSI non-donor treatment were identified. Patients were divided into two groups according to live birth and the characteristics of IVF/ICSI cycles were compared between groups, including baseline infertility parameters, ovarian stimulation characteristics and embryo laboratory manipulation parameters. The multivariate logistic regression model was performed to adjust potential confounders and assess correlation between E2 dynamics before hCG administration and live birth.
Main results and the role of chance
Our results revealed that patients without live birth had higher age (32.13 ± 4.33 vs. 30.21 ± 3.71, P < 0.001) and pervious miscarriages (0.57 ± 0.95 vs. 0.46 ± 0.83, P = 0.0295), while had lower number of oocytes retrieved (8.95 ± 4.69 vs. 12.36 ± 5.54, P < 0.001), day of hCG E2 (8269.53 ± 4104.22 vs. 9580.71 ± 3534.11, P < 0.001) and endometrium thickness (10.37 ± 3.66 vs. 11.50 ± 3.40, P < 0.001) compared with patients with live birth. Additionally, the multivariate logistic regression analysis displayed significant impact of serum E2 change on the live birth, and the achievement of live birth [OR (95%CI) 0.81 (0.71, 0.92), P = 0.001] decreased with the decreasing level of serum E2 before hCG trigger day. Estradiol stratification analyses displayed the OR and 95% CI for the association between △E2 and live birth among patients with different levels of estradiol decline (<25%, 25%–50%, 50%–75%, >75%). Compared with the <25% decline and 25%–50% decline groups, the ORs of 50%–75% and >75% decline groups were 1.66 (95% CI: 1.12-2.45, P = 0.012) and 2.00 (95% CI: 1.39-2.89, P < 0.001), respectively, after adjusting potential confounders.
Limitations, reasons for caution
There was concealment of randomization and blinding of outcome assessments reducing the risk of selection and measurement bias.
Wider implications of the findings
In summary, the E2 change before the day of hCG administration had significant correlation with live birth, and the live birth decreased with the decreasing level of serum E2 before hCG trigger day. The patients with a greater decline in the E2 level more likely to had poor clinical outcomes.
Trial registration number
Chi CTR1900026088
Collapse
Affiliation(s)
- Z Lu
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| | - Z Gong
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| | - H Wang
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| | - M Zhu
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| | - H Jiang
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| | - Y Cao
- The First Affiliated Hospital of Anhui Medical University, Reproductive Medicine Center- Department of Obstetrics and Gynecology , Hefei, China
| |
Collapse
|
33
|
Wang Z, Cai Q, Xia H, Han B, Li M, Wang Y, Zhu M, Jiao C, Wang D, Zhu J, Yuan W, Zhu D, Xu C, Wang H, Zhou M, Zhang X, Shi J, Chen J. Genome-Wide Identification and Comparative Analysis of WOX Genes in Four Euphorbiaceae Species and Their Expression Patterns in Jatropha curcas. Front Genet 2022; 13:878554. [PMID: 35846114 PMCID: PMC9280045 DOI: 10.3389/fgene.2022.878554] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 04/22/2022] [Indexed: 11/18/2022] Open
Abstract
The WUSCHEL-related homeobox (WOX) proteins are widely distributed in plants and play important regulatory roles in growth and development processes such as embryonic development and organ development. Here, series of bioinformatics methods were utilized to unravel the structural basis and genetic hierarchy of WOX genes, followed by regulation of the WOX genes in four Euphorbiaceae species. A genome-wide survey identified 59 WOX genes in Hevea brasiliensis (H. brasiliensis: 20 genes), Jatropha curcas (J. curcas: 10 genes), Manihot esculenta (M. esculenta: 18 genes), and Ricinus communis (R. communis: 11 genes). The phylogenetic analysis revealed that these WOX members could be clustered into three close proximal clades, such as namely ancient, intermediate and modern/WUS clades. In addition, gene structures and conserved motif analyses further validated that the WOX genes were conserved within each phylogenetic clade. These results suggested the relationships among WOX members in the four Euphorbiaceae species. We found that WOX genes in H. brasiliensis and M. esculenta exhibit close genetic relationship with J. curcas and R. communis. Additionally, the presence of various cis-acting regulatory elements in the promoter of J. curcas WOX genes (JcWOXs) reflected distinct functions. These speculations were further validated with the differential expression profiles of various JcWOXs in seeds, reflecting the importance of two JcWOX genes (JcWOX6 and JcWOX13) during plant growth and development. Our quantitative real-time PCR (qRT-PCR) analysis demonstrated that the JcWOX11 gene plays an indispensable role in regulating plant callus. Taken together, the present study reports the comprehensive characteristics and relationships of WOX genes in four Euphorbiaceae species, providing new insights into their characterization.
Collapse
Affiliation(s)
- Zhanjun Wang
- College of Life Sciences, Hefei Normal University, Hefei, China
- Key Laboratory of Forest Genetics and Biotechnology, Ministry of Education of China, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China
- State Key Laboratory of Utilization of Woody Oil Resource, Hunan Academy of Forestry, Changsha, China
| | - Qianwen Cai
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Haimeng Xia
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Bingqing Han
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Minhui Li
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Yue Wang
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Minhui Zhu
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Chunyan Jiao
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Dandan Wang
- Key Laboratory of Forest Genetics and Biotechnology, Ministry of Education of China, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China
| | - Junjie Zhu
- Key Laboratory of Forest Genetics and Biotechnology, Ministry of Education of China, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China
| | - Wenya Yuan
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Di Zhu
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Congcong Xu
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Hongyan Wang
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Minghui Zhou
- College of Life Sciences, Hefei Normal University, Hefei, China
| | - Xie Zhang
- State Key Laboratory of Utilization of Woody Oil Resource, Hunan Academy of Forestry, Changsha, China
| | - Jisen Shi
- Key Laboratory of Forest Genetics and Biotechnology, Ministry of Education of China, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China
| | - Jinhui Chen
- Key Laboratory of Forest Genetics and Biotechnology, Ministry of Education of China, Co-Innovation Center for the Sustainable Forestry in Southern China, Nanjing Forestry University, Nanjing, China
- *Correspondence: Jinhui Chen,
| |
Collapse
|
34
|
Zhang Y, Gao M, Zhu M, Li H, Ma T, Wu C. [Isobavachalcone induces cell death through multiple pathways in human breast cancer MCF-7 cells]. Nan Fang Yi Ke Da Xue Xue Bao 2022; 42:878-885. [PMID: 35790438 DOI: 10.12122/j.issn.1673-4254.2022.06.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To explore the effects of isobavachalcone (IBC) on cell death of human breast cancer MCF-7 cells and explore the possible mechanism. METHODS MCF-7 cells were treated with different concentrations of IBC, and the changes in cell proliferation were assessed using MTT assay. Apoptosis of MCF-7 cells following treatment with 10, 20, and 40 μmol/L IBC was analyzed using flow cytometry with annexin V-FITC/PI double staining and fluorescence microscopy, and the expressions of apoptosis- and autophagy-related proteins (Bax, Bcl-2, Akt, p-Akt, p62, and LC3) were detected with Western blotting. Electron microscopy was used to observe the changes in submicrostructure of the cells following treatment with 40 μmol/L IBC. JC-1 assay kit, ATP assay kit, and reactive oxygen species (ROS) kit were used to determine the effect of IBC on mitochondrial function of the cells. RESULTS MTT assay showed that IBC significantly inhibited the proliferation of MCF-7 cells in a concentration- and time-dependent manner, with IC50 values of 38.46, 31.31, and 28.26 μmol/L at 24, 48, and 72 h, respectively. IBC also concentration-dependently induced apoptosis of MCF-7 cells. IBC-induced cell death was inhibited by z-VAD-fmk, a caspase inhibitor (P < 0.05), but not by the necroptosis inhibitor necrostatin-1 (Nec-1). Western blotting showed that IBC-induced MCF-7 cell apoptosis by increasing Bax expression and down-regulating the expressions of Bcl-2, Akt and p-Akt-473 (all P < 0.05). With the increase of IBC concentration, the expression of autophagy-related protein p62 and the LC3-II/I ratio increased progressively. Electron microscopy revealed the presence of autophagic bodies in IBC-treated MCF-7 cells. IBC treatment also resulted in decreased mitochondrial membrane potential and intracellular ATP level and increased ROS accumulation in MCF-7 cells (P < 0.05). CONCLUSION IBC is capable of inducing both apoptosis and autophagy in MCF-7 cells, suggesting the potential value of IBC as a lead compound in the development of anti-breast cancer agents.
Collapse
Affiliation(s)
- Y Zhang
- School of Laboratory Medicine, Bengbu Medical College, Bengbu 233030, China
| | - M Gao
- School of Pharmacy, Bengbu Medical College, Bengbu 233030, China
| | - M Zhu
- School of Pharmacy, Bengbu Medical College, Bengbu 233030, China
| | - H Li
- School of Pharmacy, Bengbu Medical College, Bengbu 233030, China
| | - T Ma
- School of Pharmacy, Bengbu Medical College, Bengbu 233030, China
| | - C Wu
- School of Pharmacy, Bengbu Medical College, Bengbu 233030, China
| |
Collapse
|
35
|
He F, Wang Y, Tao X, Zhu M, Hong Z, Bian Z, Ma J. [Low-dose helical CT projection data restoration using noise estimation]. Nan Fang Yi Ke Da Xue Xue Bao 2022; 42:849-859. [PMID: 35790435 DOI: 10.12122/j.issn.1673-4254.2022.06.08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To build a helical CT projection data restoration model at random low-dose levels. METHODS We used a noise estimation module to achieve noise estimation and obtained a low-dose projection noise variance map, which was used to guide projection data recovery by the projection data restoration module. A filtering back-projection algorithm (FBP) was finally used to reconstruct the images. The 3D wavelet group residual dense network (3DWGRDN) was adopted to build the network architecture of the noise estimation and projection data restoration module using asymmetric loss and total variational regularization. For validation of the model, 1/10 and 1/15 of normal dose helical CT images were restored using the proposed model and 3 other restoration models (IRLNet, REDCNN and MWResNet), and the results were visually and quantitatively compared. RESULTS Quantitative comparisons of the restored images showed that the proposed helical CT projection data restoration model increased the structural similarity index by 5.79% to 17.46% compared with the other restoration algorithms (P < 0.05). The image quality scores of the proposed method rated by clinical radiologists ranged from 7.19% to 17.38%, significantly higher than the other restoration algorithms (P < 0.05). CONCLUSION The proposed method can effectively suppress noises and reduce artifacts in the projection data at different low-dose levels while preserving the integrity of the edges and fine details of the reconstructed CT images.
Collapse
Affiliation(s)
- F He
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou, 510330, China
| | - Y Wang
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou, 510330, China
| | - X Tao
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
| | - M Zhu
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou, 510330, China
| | - Z Hong
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou, 510330, China
| | - Z Bian
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
| | - J Ma
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
36
|
Zhu Q, Wang Y, Zhu M, Tao X, Bian Z, Ma J. [An adaptive CT metal artifact reduction algorithm that combines projection interpolation and physical correction]. Nan Fang Yi Ke Da Xue Xue Bao 2022; 42:832-839. [PMID: 35790433 DOI: 10.12122/j.issn.1673-4254.2022.06.06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To propose an adaptive weighted CT metal artifact reduce algorithm that combines projection interpolation and physical correction. METHODS A normalized metal projection interpolation algorithm was used to obtain the initial corrected projection data. A metal physical correction model was then introduced to obtain the physically corrected projection data. To verify the effectiveness of the method, we conducted experiments using simulation data and clinical data. For the simulation data, the quantitative indicators PSNR and SSIM were used for evaluation, while for the clinical data, the resultant images were evaluated by imaging experts to compare the artifact-reducing performance of different methods. RESULTS For the simulation data, the proposed method improved the PSNR value by at least 0.2 dB and resulted in the highest SSIM value among the methods for comparison. The experiment with the clinical data showed that the imaging experts gave the highest scores of 3.616±0.338 (in a 5-point scale) to the images processed using the proposed method, which had significant better artifact-reducing performance than the other methods (P < 0.001). CONCLUSION The metal artifact reduction algorithm proposed herein can effectively reduce metal artifacts while preserving the tissue structure information and reducing the generation of new artifacts.
Collapse
Affiliation(s)
- Q Zhu
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou 510330, China
| | - Y Wang
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou 510330, China
| | - M Zhu
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou 510330, China
| | - X Tao
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.,Pazhou Lab, Guangzhou 510330, China
| | - Z Bian
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
| | - J Ma
- School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
| |
Collapse
|
37
|
Yan H, Li W, Liu X, Zhu M, Wang M. Morphological Structure and Basic Characteristics of Miscanthus floridulus Fibers. ACS Omega 2022; 7:19412-19419. [PMID: 35721997 PMCID: PMC9202036 DOI: 10.1021/acsomega.2c01025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 05/17/2022] [Indexed: 06/15/2023]
Abstract
Miscanthus floridulus fibers obtained from the seed floss of M. floridulus (a perinneal plant of Gramineae native to Africa and Asia and widely distributed in tropical and subtropical regions) have potential application value in textile and other fields. At present, the biological characteristics and ecological benefits of Miscanthus floridus have been extensively studied by researchers, but there have been no literature on M. floridus fibers. In order to make reasonable use of M. floridus fibers, their morphological structure, physical properties, chemical composition, thermal insulation properties, and surface absorption properties were explored in detail in this study. The results showed that the M. floridus fiber is fine and short and has a hollow structure with a density of 0.67 g cm-3. Chemical analyses revealed that the main constituents of the fiber are cellulose (66.98%), hemicelluloses (13.86%), lignin (6.97%), pectin (1.99%), and wax (4.38%). The fill power and warmth retention performance of the fiber are similar to those of wool. In particular, the M. floridus fiber surface has hydrophobic and lipophilic properties with a static contact angle of 123.7° for water droplets in equilibrium. Therefore, the M. floridus fiber has a promising application prospect in bulk textile thermal insulation and oil-water separation fields.
Collapse
Affiliation(s)
- Hongqin Yan
- School
of Textile and Garment, Anhui Polytechnic
University, Wuhu 241000, China
- Key
Laboratory of Textile Science & Technology of Anhui Province, Wuhu 241000, China
| | - Wei Li
- School
of Textile and Garment, Anhui Polytechnic
University, Wuhu 241000, China
- Anhui
Engineering and Technology Research Center of Textile, Wuhu 241000, China
| | - Xin Liu
- School
of Textile and Garment, Anhui Polytechnic
University, Wuhu 241000, China
| | - Minhui Zhu
- School
of Textile and Garment, Anhui Polytechnic
University, Wuhu 241000, China
| | - Mengran Wang
- School
of Textile and Garment, Anhui Polytechnic
University, Wuhu 241000, China
| |
Collapse
|
38
|
Zhu M. The Air Flow Distributions within a Typical Planar Protonic Ceramic Fuel Cell Stack. INT J ELECTROCHEM SC 2022. [DOI: 10.20964/2022.06.64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
39
|
Yu Q, Pan H, Jiang L, Zhu M, Jin YJ, Wang ZY. [Potential transmission risk of key parasitic diseases and responses to the risk during the construction of an ecological city in Shanghai Municipality]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2022; 34:531-536. [PMID: 36464251 DOI: 10.16250/j.32.1374.2021217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
A blueprint on Shanghai's ecological space design between 2021 and 2035 was released in 2021, aiming to build an ecological city and improve the development of ecological civilization. The transmission of parasitic diseases is strongly associated with climate and ecological environments. Currently, the prevalence of parasitic diseases has been maintained at extremely low-transmission levels, and there are almost no local cases; however, the alteration of ecological environments may results in a potential transmission risk of parasitic diseases. Hereby, the current status of key parasitic diseases in Shanghai Municipality was described, and the potential transmission risk of parasitic diseases and responses to this risk were analyzed during the construction of an ecological city in Shanghai Municipality. In addition, the suggestions pertaining to surveillance and management of parasitic diseases were proposed during the mid- and long-term construction of an ecological city in Shanghai Municipality.
Collapse
Affiliation(s)
- Q Yu
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
- Co-first authors
| | - H Pan
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
- Co-first authors
| | - L Jiang
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
| | - M Zhu
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
| | - Y J Jin
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
| | - Z Y Wang
- Shanghai Center for Disease Control and Prevention, Shanghai Institutes of Prevention Medicine, Shanghai 200336, China
| |
Collapse
|
40
|
Zhou P, Zhang C, Song X, Zhang D, Zhu M, Zheng H. ΔNp63α promotes Bortezomib resistance via the CYGB-ROS axis in head and neck squamous cell carcinoma. Cell Death Dis 2022; 13:327. [PMID: 35397613 PMCID: PMC8994767 DOI: 10.1038/s41419-022-04790-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2021] [Revised: 03/01/2022] [Accepted: 03/21/2022] [Indexed: 01/07/2023]
Abstract
Bortezomib, a proteasome inhibitor, proved potent in the treatment of recurrent multiple myeloma or mantle cell lymphoma. However, slow progress was made when it was applied to treat solid tumors. We discovered that different head and neck squamous cell carcinoma (HNSCC) cell lines had significantly different sensitivities to bortezomib, and also demonstrated that individual relatively sensitive HNSCC cell lines had fewer ΔNp63α expressions. Based on these findings, we speculated that ΔNp63α may be a key factor in the resistance of HNSCC cells to bortezomib. ΔNp63α knockdown made HNSCC more sensitive to bortezomib, while ΔNp63α overexpression made it more resistant. RNA sequencing (RNA-seq) analysis of ΔNp63α-knockdown cells revealed clear alterations in the subset of genes that were associated with oxidative stress and antioxidant defense. The gene CYGB was downregulated significantly. CHIP-seq detection showed that CYGB was the transcriptional regulatory site of ΔNp63α. CHIP-PCR showed evidence of ΔNp63α binding. The detection of the dual-luciferase reporter gene demonstrated that ΔNp63α significantly enhanced the CYGB promoter activity. Furthermore, we confirmed that CYGB plays a role in clearing excess ROS induced by bortezomib to inhibit HNSCC apoptosis. Consequently, ΔNp63α regulated the expression of CYGB in HNSCC. CYGB was the target of transcription regulation of ΔNp63α. It reduced apoptosis by clearing excess ROS produced by bortezomib, and thus exerted drug resistance.
Collapse
Affiliation(s)
- Peng Zhou
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.,Department of Otorhinolaryngology-Head and Neck Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221003, China
| | - Caiyun Zhang
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China
| | - Xianmin Song
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China
| | - Dadong Zhang
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.,3D Medicines Inc., Shanghai, 201114, China
| | - Minhui Zhu
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
| | - Hongliang Zheng
- Department of Otorhinolaryngology-Head and Neck Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
| |
Collapse
|
41
|
Xia CM, Zhu M, Ji PZ, Liu B, Yang YL. [Primary extramedullary plasma cell tumor of the right kidney: report of a case]. Zhonghua Bing Li Xue Za Zhi 2022; 51:360-362. [PMID: 35359052 DOI: 10.3760/cma.j.cn112151-20210830-00628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- C M Xia
- Department of Pathology, the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Lanzhou 730000, China
| | - M Zhu
- Department of Pathology, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
| | - P Z Ji
- Department of Pathology, the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Lanzhou 730000, China
| | - B Liu
- Department of Pathology, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China
| | - Y L Yang
- Department of Pathology, the 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Lanzhou 730000, China
| |
Collapse
|
42
|
Xu XQ, Zhang JW, Chen RM, Luo JS, Chen SK, Zheng RX, Wu D, Zhu M, Wang CL, Liang Y, Yao H, Wei HY, Su Z, Maimaiti M, Du HW, Luo FH, Li P, Si ST, Wu W, Huang K, Dong GP, Yu YX, Fu JF. [Relationship between body mass index and sexual development in Chinese children]. Zhonghua Er Ke Za Zhi 2022; 60:311-316. [PMID: 35385936 DOI: 10.3760/cma.j.cn112140-20210906-00754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To investigate the relationship between body mass index (BMI) and sexual development in Chinese children. Methods: A nationwide multicenter and population-based large cross-sectional study was conducted in 13 provinces, autonomous regions and municipalities of China from January 2017 to December 2018. Data on sex, age, height, weight were collected, BMI was calculated and sexual characteristics were analyzed. The subjects were divided into four groups based on age, including ages 3-<6 years, 6-<10 years, 10-<15 years and 15-<18 years. Multiple Logistic regression models were used for evaluating the associations of BMI with sexual development in children. Dichotomous Logistic regression was used to compare the differences in the distribution of early and non-early puberty among normal weight, overweight and obese groups. Curves were drawn to analyze the relationship between the percentage of early puberty and BMI distribution in girls and boys at different Tanner stages. Results: A total of 208 179 healthy children (96 471 girls and 111 708 boys) were enrolled in this study. The OR values of B2, B3 and B4+ in overweight girls were 1.72 (95%CI: 1.56-1.89), 3.19 (95%CI: 2.86-3.57), 7.14 (95%CI: 6.33-8.05) and in obese girls were 2.05 (95%CI: 1.88-2.24), 4.98 (95%CI: 4.49-5.53), 11.21 (95%CI: 9.98-12.59), respectively; while the OR values of G2, G3, G4+ in overweight boys were 1.27 (95%CI: 1.17-1.38), 1.52 (95%CI: 1.36-1.70), 1.88 (95%CI: 1.66-2.14) and in obese boys were 1.27 (95%CI: 1.17-1.37), 1.59 (95%CI: 1.43-1.78), and 1.93 (95%CI: 1.70-2.18) (compared with normal weight Tanner 1 group,all P<0.01). Analysis in different age groups found that OR values of obese girls at B2 stage and boys at G2 stage were 2.02 (95%CI: 1.06-3.86) and 2.32 (95%CI:1.05-5.12) in preschool children aged 3-<6 years, respectively (both P<0.05). And in the age group of 6-10 years, overweight girls had a 5.45-fold risk and obese girls had a 12.54-fold risk of B3 stage compared to girls with normal BMI. Compared with normal weight children, the risk of early puberty was 2.67 times higher in overweight girls, 3.63 times higher in obese girls, and 1.22 times higher in overweight boys, 1.35 times higher in obese boys (all P<0.01). Among the children at each Tanner stages, the percentage of early puberty increased with the increase of BMI, from 5.7% (80/1 397), 16.1% (48/299), 13.8% (27/195) to 25.7% (198/769), 65.1% (209/321), 65.4% (157/240) in girls aged 8-<9, 10-<11 and 11-<12 years, and 6.6% (34/513), 18.7% (51/273), 21.6% (57/264) to 13.3% (96/722), 46.4% (140/302), 47.5% (105/221) in boys aged 9-<10, 12-<13 and 13-<14 years, respectively. Conclusions: BMI is positively correlated with sexual development in both Chinese boys and girls, and the correlation is stronger in girls. Obesity is a risk factor for precocious puberty in preschool children aged 3-<6 years, and 6-<10 years of age is a high risk period for early development in obese girls.
Collapse
Affiliation(s)
- X Q Xu
- Department of Endocrinology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - J W Zhang
- Department of Pediatrics, Shaoxing Maternity and Child Health Care Hospital, Shaoxing 312000, China
| | - R M Chen
- Department of Endocrinology, Fuzhou Children's Hospital of Fujian Province, Fuzhou 350000, China
| | - J S Luo
- Department of Endocrinology and Genetic Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, China
| | - S K Chen
- Department of Endocrinology and Genetic Diseases, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, China
| | - R X Zheng
- Department of Pediatrics, Tianjin Medical University General Hospital, Tianjin 350002, China
| | - D Wu
- Department of Endocrinology Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - C L Wang
- Department of Pediatrics, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310053, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - H Yao
- Department of Genetic Metabolism and Endocrinology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China
| | - H Y Wei
- Department of Endocrinology and Metabolism, Genetics, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450000, China
| | - Z Su
- Department of Endocrinology, Shenzhen Children's Hospital, Shenzhen 518028, China
| | - Mireguli Maimaiti
- Department of Pediatrics, the First Affiliated Hospital of Xinjiang Medical University, Urumchi 830054, China
| | - H W Du
- Department of Pediatrics, the First Bethune Hospital of Jilin University, Changchun 130021, China
| | - F H Luo
- Department of Endocrinology, Children's Hospital of Fudan University, Shanghai 201102, China
| | - P Li
- Department of Endocrinology, Children's Hospital of Shanghai, Shanghai 200062, China
| | - S T Si
- School of Public Health, Zhejiang University, Hangzhou 310014, China
| | - W Wu
- Department of Endocrinology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - K Huang
- Department of Endocrinology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - G P Dong
- Department of Endocrinology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - Y X Yu
- School of Public Health, Zhejiang University, Hangzhou 310014, China
| | - J F Fu
- Department of Endocrinology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| |
Collapse
|
43
|
Zhu M, Yuan L, Wu Y, Chu L, Wang W, Zhang H, Liao W, Peng X, Deng H. Simultaneous LC-MS/MS quantification of glucocorticoids, melatonin and its metabolites in hair. J Chromatogr B Analyt Technol Biomed Life Sci 2022; 1196:123217. [DOI: 10.1016/j.jchromb.2022.123217] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Revised: 02/21/2022] [Accepted: 03/08/2022] [Indexed: 11/29/2022]
|
44
|
Zhu M, Zhang C, Zhou P, Chen S, Zheng H. LncRNA CASC15 upregulates cyclin D1 by downregulating miR-365 in laryngeal squamous cell carcinoma to promote cell proliferation. J Otolaryngol Head Neck Surg 2022; 51:8. [PMID: 35216636 PMCID: PMC8881844 DOI: 10.1186/s40463-022-00560-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 01/31/2022] [Indexed: 12/13/2022] Open
Abstract
Background This study investigated the role of lncRNA CASC15 in laryngeal squamous cell carcinoma (LSCC). Methods This study included 58 LSCC patients. Both tumor (LSCC) and adjacent (within 3 cm around tumors) non-tumor tissues from 3 different sites of each patient were collected. CCK-8 assay was used to determine cell proliferation. The expression levels of proteins and mRNAs were determined by Western blotting analysis and qRT-PCRs, respectively. Results CASC15 was upregulated in LSCC and high expression levels of CASC15 predicted poor survival. In LSCC tissues, CASC15 was negatively correlated with miR-365 but positively correlated with cyclin D1. In LSCC cells, overexpression of CASC15 resulted in downregulation of miR-365 and upregulation of cyclin D1. Overexpression of miR-365 did not affect the expression of CASC15 but downregulated cyclin D1. Overexpression of Cyclin D1 did not affect the expression of miR-365 and CASC15. Overexpression of CASC15 and cyclin D1 led to promoted, while overexpression of miR-365 led to inhibited LSCC cell proliferation. In addition, overexpression of miR-365 reduced the effects of overexpression of CASC15. Conclusion Therefore, CASC15 upregulates cyclin D1 by downregulating miR-365 in LSCC to promote cell proliferation.
Collapse
Affiliation(s)
- Minhui Zhu
- Department of Otorhinolaryngology Head and Neck Surgery, Changhai Hospital, Navy Military Medical University, No. 168 Changhai Road, Shanghai, 200433, People's Republic of China
| | - Caiyun Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Changhai Hospital, Navy Military Medical University, No. 168 Changhai Road, Shanghai, 200433, People's Republic of China
| | - Peng Zhou
- Department of Otorhinolaryngology Head and Neck Surgery, Changhai Hospital, Navy Military Medical University, No. 168 Changhai Road, Shanghai, 200433, People's Republic of China
| | - Shicai Chen
- Department of Otorhinolaryngology Head and Neck Surgery, Changhai Hospital, Navy Military Medical University, No. 168 Changhai Road, Shanghai, 200433, People's Republic of China.
| | - Hongliang Zheng
- Department of Otorhinolaryngology Head and Neck Surgery, Changhai Hospital, Navy Military Medical University, No. 168 Changhai Road, Shanghai, 200433, People's Republic of China.
| |
Collapse
|
45
|
Barnes PW, Robson TM, Neale PJ, Williamson CE, Zepp RG, Madronich S, Wilson SR, Andrady AL, Heikkilä AM, Bernhard GH, Bais AF, Neale RE, Bornman JF, Jansen MAK, Klekociuk AR, Martinez-Abaigar J, Robinson SA, Wang QW, Banaszak AT, Häder DP, Hylander S, Rose KC, Wängberg SÅ, Foereid B, Hou WC, Ossola R, Paul ND, Ukpebor JE, Andersen MPS, Longstreth J, Schikowski T, Solomon KR, Sulzberger B, Bruckman LS, Pandey KK, White CC, Zhu L, Zhu M, Aucamp PJ, Liley JB, McKenzie RL, Berwick M, Byrne SN, Hollestein LM, Lucas RM, Olsen CM, Rhodes LE, Yazar S, Young AR. Environmental effects of stratospheric ozone depletion, UV radiation, and interactions with climate change: UNEP Environmental Effects Assessment Panel, Update 2021. Photochem Photobiol Sci 2022; 21:275-301. [PMID: 35191005 PMCID: PMC8860140 DOI: 10.1007/s43630-022-00176-5] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Accepted: 01/14/2022] [Indexed: 12/07/2022]
Abstract
The Environmental Effects Assessment Panel of the Montreal Protocol under the United Nations Environment Programme evaluates effects on the environment and human health that arise from changes in the stratospheric ozone layer and concomitant variations in ultraviolet (UV) radiation at the Earth’s surface. The current update is based on scientific advances that have accumulated since our last assessment (Photochem and Photobiol Sci 20(1):1–67, 2021). We also discuss how climate change affects stratospheric ozone depletion and ultraviolet radiation, and how stratospheric ozone depletion affects climate change. The resulting interlinking effects of stratospheric ozone depletion, UV radiation, and climate change are assessed in terms of air quality, carbon sinks, ecosystems, human health, and natural and synthetic materials. We further highlight potential impacts on the biosphere from extreme climate events that are occurring with increasing frequency as a consequence of climate change. These and other interactive effects are examined with respect to the benefits that the Montreal Protocol and its Amendments are providing to life on Earth by controlling the production of various substances that contribute to both stratospheric ozone depletion and climate change.
Collapse
Affiliation(s)
- P W Barnes
- Biological Sciences and Environment Program, Loyola University New Orleans, New Orleans, USA
| | - T M Robson
- Organismal and Evolutionary Biology (OEB), Viikki Plant Science Centre (ViPS), University of Helsinki, Helsinki, Finland
| | - P J Neale
- Smithsonian Environmental Research Center, Edgewater, USA
| | | | - R G Zepp
- ORD/CEMM, US Environmental Protection Agency, Athens, GA, USA
| | - S Madronich
- Atmospheric Chemistry Observations and Modeling Laboratory, National Center for Atmospheric Research, Boulder, USA
| | - S R Wilson
- School of Earth, Atmospheric and Life Sciences, University of Wollongong, Wollongong, Australia
| | - A L Andrady
- Chemical and Biomolecular Engineering, North Carolina State University, Apex, USA
| | - A M Heikkilä
- Finnish Meteorological Institute, Helsinki, Finland
| | | | - A F Bais
- Laboratory of Atmospheric Physics, Department of Physics, Aristotle University, Thessaloniki, Greece
| | - R E Neale
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - J F Bornman
- Food Futures Institute, Murdoch University, Perth, Australia.
| | | | - A R Klekociuk
- Antarctic Climate Program, Australian Antarctic Division, Kingston, Australia
| | - J Martinez-Abaigar
- Faculty of Science and Technology, University of La Rioja, La Rioja, Logroño, Spain
| | - S A Robinson
- Securing Antarctica's Environmental Future, Global Challenges Program and School of Earth, Atmospheric and Life Sciences, University of Wollongong, Wollongong, Australia
| | - Q-W Wang
- Institute of Applied Ecology, Chinese Academy of Sciences (CAS), Shenyang, China
| | - A T Banaszak
- Unidad Académica De Sistemas Arrecifales, Universidad Nacional Autónoma De México, Puerto Morelos, Mexico
| | - D-P Häder
- Department of Biology, Friedrich-Alexander University, Möhrendorf, Germany
| | - S Hylander
- Centre for Ecology and Evolution in Microbial Model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
| | - K C Rose
- Biological Sciences, Rensselaer Polytechnic Institute, Troy, USA
| | - S-Å Wängberg
- Marine Sciences, University of Gothenburg, Gothenburg, Sweden
| | - B Foereid
- Environment and Natural Resources, Norwegian Institute of Bioeconomy Research, Ås, Norway
| | - W-C Hou
- Environmental Engineering, National Cheng Kung University, Tainan, Taiwan
| | - R Ossola
- Environmental System Science (D-USYS), ETH Zürich, Zürich, Switzerland
| | - N D Paul
- Lancaster Environment Centre, Lancaster University, Lancaster, UK
| | - J E Ukpebor
- Chemistry Department, Faculty of Physical Sciences, University of Benin, Benin City, Nigeria
| | - M P S Andersen
- Department of Chemistry and Biochemistry, California State University, Northridge, USA
- Department of Chemistry, University of Copenhagen, Copenhagen, Denmark
| | - J Longstreth
- The Institute for Global Risk Research, LLC, Bethesda, USA
| | - T Schikowski
- Research Group of Environmental Epidemiology, Leibniz Institute of Environmental Medicine, Düsseldorf, Germany
| | - K R Solomon
- Centre for Toxicology, School of Environmental Sciences, University of Guelph, Guelph, Canada
| | - B Sulzberger
- Academic Guest, Swiss Federal Institute of Aquatic Science and Technology, 8600, Dübendorf, Switzerland
| | - L S Bruckman
- Materials Science and Engineering, Case Western Reserve University, Cleveland, USA
| | - K K Pandey
- Wood Processing Division, Institute of Wood Science and Technology, Bangalore, India
| | - C C White
- Polymer Science and Materials Chemistry (PSMC), Exponent, Bethesda, USA
| | - L Zhu
- College of Materials Science and Engineering, Donghua University, Shanghai, China
| | - M Zhu
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University, Shanghai, China
| | - P J Aucamp
- Ptersa Environmental Consultants, Pretoria, South Africa
| | - J B Liley
- National Institute of Water and Atmospheric Research, Alexandra, New Zealand
| | - R L McKenzie
- National Institute of Water and Atmospheric Research, Alexandra, New Zealand
| | - M Berwick
- Internal Medicine, University of New Mexico, Albuquerque, USA
| | - S N Byrne
- Applied Medical Science, University of Sydney, Sydney, Australia
| | - L M Hollestein
- Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - R M Lucas
- National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia
| | - C M Olsen
- Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - L E Rhodes
- Photobiology Unit, Dermatology Research Centre, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK
| | - S Yazar
- Garvan Institute of Medical Research, Sydney, Australia
| | - A R Young
- St John's Institute of Dermatology, King's College London (KCL), London, UK
| |
Collapse
|
46
|
Tam CC, Zhu M, Ayres J, Kummer K, Yakhou-Harris F, Cooper JR, Carrington A, Hayden SM. Charge density waves and Fermi surface reconstruction in the clean overdoped cuprate superconductor Tl 2Ba 2CuO 6+δ. Nat Commun 2022; 13:570. [PMID: 35091572 PMCID: PMC8799688 DOI: 10.1038/s41467-022-28124-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 01/10/2022] [Indexed: 12/03/2022] Open
Abstract
Hall effect and quantum oscillation measurements on high temperature cuprate superconductors show that underdoped compositions have small Fermi surface pockets whereas when heavily overdoped, a single much larger pocket is found. The origin of this change in electronic structure has been unclear, but may be related to the high temperature superconductivity. Here we show that the clean overdoped single-layer cuprate Tl2Ba2CuO6+δ (Tl2201) displays CDW order with a remarkably long correlation length ξ ≈ 200 Å which disappears above a hole doping of pCDW ≈ 0.265. We show that the evolution of the electronic properties of Tl2201 as the doping is lowered may be explained by a Fermi surface reconstruction which accompanies the emergence of the CDW below pCDW. Our results demonstrate importance of CDW correlations in understanding the electronic properties of overdoped cuprates. The origin of the Fermi surface reconstruction that occurs in cuprate superconductors as hole doping increases remains unclear. Here, the authors observe long range charge density wave (CDW) order in the overdoped single-layer cuprate Tl2Ba2CuO6+δ, which then disappears above a hole concentration 0.265, suggesting a correlation between Fermi surface reconstruction and the emergence of the CDW.
Collapse
Affiliation(s)
- C C Tam
- H. H. Wills Physics Laboratory, University of Bristol, Bristol, BS8 1TL, United Kingdom.,Diamond Light Source, Harwell Campus, Didcot, OX11 0DE, United Kingdom
| | - M Zhu
- H. H. Wills Physics Laboratory, University of Bristol, Bristol, BS8 1TL, United Kingdom
| | - J Ayres
- H. H. Wills Physics Laboratory, University of Bristol, Bristol, BS8 1TL, United Kingdom
| | - K Kummer
- ESRF, The European Synchrotron, 71 Avenue des Martyrs, CS40220, 38043, Grenoble Cedex 9, France
| | - F Yakhou-Harris
- ESRF, The European Synchrotron, 71 Avenue des Martyrs, CS40220, 38043, Grenoble Cedex 9, France
| | - J R Cooper
- Department of Physics, University of Cambridge, Madingley Road, Cambridge, CB3 0HE, United Kingdom
| | - A Carrington
- H. H. Wills Physics Laboratory, University of Bristol, Bristol, BS8 1TL, United Kingdom.
| | - S M Hayden
- H. H. Wills Physics Laboratory, University of Bristol, Bristol, BS8 1TL, United Kingdom.
| |
Collapse
|
47
|
Zhou H, Zhu X, Yao Y, Su Y, Xie J, Zhu M, He C, Ding J, Xu Y, Shan R, Wang Y, Zhao X, Ding Y, Liu B, Shao Z, Liu Y, Xu T, Xie Y. TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease. Front Pharmacol 2022; 12:798735. [PMID: 35058782 PMCID: PMC8764240 DOI: 10.3389/fphar.2021.798735] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 11/29/2021] [Indexed: 01/13/2023] Open
Abstract
Objective: To clarify the molecular mechanism of TMEM88 regulating lipid synthesis and metabolism cytokine in NAFLD. Methods:In vivo, NAFLD model mice were fed by a Methionine and Choline-Deficient (MCD) diet. H&E staining and immunohistochemistry experiments were used to analyze the mice liver tissue. RT-qPCR and Western blotting were used to detect the lipid synthesis and metabolism cytokine. In vitro, pEGFP-C1-TMEM88 and TMEM88 siRNA were transfected respectively in free fat acid (FFA) induced AML-12 cells, and the expression level of SREBP-1c, PPAR-α, FASN, and ACOX-1 were evaluated by RT-qPCR and Western blotting. Results: The study found that the secretion of PPAR-α and its downstream target ACOX-1 were upregulated, and the secretion of SREBP-1c and its downstream target FASN were downregulated after transfecting with pEGFP-C1-TMEM88. But when TMEM88 was inhibited, the experimental results were opposite to the aforementioned conclusions. The data suggested that it may be related to the occurrence, development, and end of NAFLD. Additionally, the study proved that TMEM88 can inhibit Wnt/β-catenin signaling pathway. Meanwhile, TMEM88 can accelerate the apoptotic rate of FFA-induced AML-12 cells. Conclusion: Overall, the study proved that TMEM88 takes part in regulating the secretion of lipid synthesis and metabolism cytokine through the Wnt/β-catenin signaling pathway in AML-12 cells. Therefore, TMEM88 may be involved in the progress of NAFLD. Further research will bring new ideas for the study of NAFLD.
Collapse
Affiliation(s)
- Huan Zhou
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China.,School of Public Foundation, Bengbu Medical University, Bengbu, China
| | - Xingyu Zhu
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Yan Yao
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China
| | - Yue Su
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Public Foundation, Bengbu Medical University, Bengbu, China
| | - Jing Xie
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Minhui Zhu
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Cuixia He
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Jiaxiang Ding
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Public Foundation, Bengbu Medical University, Bengbu, China
| | - Yuanyuan Xu
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Rongfang Shan
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Ying Wang
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Xiangdi Zhao
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.,School of Pharmacy, Bengbu Medical College, Bengbu, China
| | - Yuzhou Ding
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Bingyan Liu
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Zhonghuan Shao
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Yuanyuan Liu
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - Tao Xu
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China
| | - Yunqiu Xie
- National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| |
Collapse
|
48
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Fu JF. [Summary of the Forum on Standardized Diagnosis,Treatment and Management of Pediatric Diseases: the 20th National Pediatric Endocrine and Genetic Metabolic Diseases Conference in 2021]. Zhonghua Er Ke Za Zhi 2022; 60:74-75. [PMID: 34986630 DOI: 10.3760/cma.j.cn112140-20211123-00981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- W Wu
- Department of Endocrinology, Children's Hospital,Zhejiang University School of Medicine, Hangzhou 310052, China
| | - W Wu
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - C X Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J F Fu
- Department of Endocrinology, Children's Hospital,Zhejiang University School of Medicine, Hangzhou 310052, China
| |
Collapse
|
49
|
Abstract
BACKGROUND AND AIMS To compare the association of geriatric nutritional risk index (GNRI) and controlling nutritional status (CONUT) scores with malnutrition, and to study their association with clinical outcomes in older adult cancer patients. METHODS This retrospective analysis was conducted on 854 older adult cancer patients collected from 34 hospitals in 18 cities in China between June and September 2014. Anthropometric and hematological examination results at admission were collected, and subjective global assessment was used. Clinical outcomes, such as complications, length of hospital stays, and hospital costs, were recorded. Receiver operating characteristic curves were used to evaluate the accuracy of the two nutritional assessment tools for malnutrition. The association between GNRI and CONUT score and clinical outcomes was analyzed using the chi-square test, t-test, or rank sum test. RESULTS Among 854 patients with cancer, the prevalence of malnutrition was 42.7%. Compared with subjective global assessment, the GNRI had a significantly higher accuracy than the CONUT score in predicting malnutrition (area under the curve 0.704, 95% confidence interval, 0.658 - 0.750, P < 0.001). The GNRI was significantly associated with the occurrence of complications (χ2 = 4.985, P = 0.026), and low GNRI (≤98) was associated with a longer length of hospital stay (t = -2.179, P = 0.030). CONCLUSIONS The GNRI may be used to assess malnutrition in older adult cancer patients and can predict poor clinical outcomes in these patients.
Collapse
Affiliation(s)
- C Liu
- Mingwei Zhu, Hongyuan Cui, Department of General Surgery, Department of Hepato-bilio-pancreatic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, 100730, Beijing, China, ;
| | | | | | | | | | | | | |
Collapse
|
50
|
Agoglia AE, Zhu M, Quadir SG, Bluitt MN, Douglass E, Hanback T, Tella J, Ying R, Hodge CW, Herman MA. Sex-specific plasticity in CRF regulation of inhibitory control in central amygdala CRF1 neurons after chronic voluntary alcohol drinking. Addict Biol 2022; 27:e13067. [PMID: 34075665 PMCID: PMC8636550 DOI: 10.1111/adb.13067] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2020] [Revised: 04/01/2021] [Accepted: 05/14/2021] [Indexed: 01/03/2023]
Abstract
Despite strong preclinical evidence for the ability of corticotropin releasing factor 1 (CRF1) antagonists to regulate alcohol consumption, clinical trials have not yet demonstrated therapeutic effects of these compounds in alcohol use disorder (AUD) patients. Several confounding factors may limit the translation of preclinical CRF1 research to patients, including reliance on experimenter-administered alcohol instead of voluntary consumption, a preponderance of evidence collected in male subjects only and an inability to assess the effects of alcohol on specific brain circuits. A population of particular interest is the CRF1-containing neurons of the central amygdala (CeA). CRF1 CeA neurons are sensitive to ethanol, but the effects of alcohol drinking on CRF signalling within this population are unknown. In the present study, we assessed the effects of voluntary alcohol drinking on inhibitory control of CRF1+ CeA neurons from male and female CRF1:GFP mice using ex vivo electrophysiology and determined the contributions of CRF1 signalling to inhibitory control and voluntary alcohol drinking. Chronic alcohol drinking produced neuroadaptations in CRF1+ neurons that increased the sensitivity of GABAA receptor-mediated sIPSCs to the acute effects of alcohol, CRF and the CRF1 antagonist R121919, but these adaptations were more pronounced in male versus female mice. The CRF1 antagonist CP-154,526 reduced voluntary alcohol drinking in both sexes and abolished sex differences in alcohol drinking. The lack of alcohol-induced adaptation in the female CRF1 system may be related to the elevated alcohol intake exhibited by female mice and could contribute to the ineffectiveness of CRF1 antagonists in female AUD patients.
Collapse
Affiliation(s)
- AE Agoglia
- Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599,Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - M Zhu
- Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - SG Quadir
- Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599,Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - MN Bluitt
- Curriculum in Neurobiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - E Douglass
- Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - T Hanback
- Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - J Tella
- Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - R Ying
- Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - CW Hodge
- Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599,Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599,Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| | - MA Herman
- Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599,Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
| |
Collapse
|